| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coactivator activity | BCL9L NCOA3 NCOA6 ARID1B KMT2D NCOA1 MAML2 BCL9 SS18 CREBBP EP300 | 1.12e-10 | 303 | 48 | 11 | GO:0003713 |
| GeneOntologyMolecularFunction | transcription coregulator activity | BCL9L NCOA3 NCOA6 ARID1B KMT2D MED8 NCOA1 MAML2 BCL9 SS18 CREBBP CNOT2 EP300 | 4.74e-10 | 562 | 48 | 13 | GO:0003712 |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 1.71e-07 | 21 | 48 | 4 | GO:0042975 | |
| GeneOntologyMolecularFunction | chromatin binding | FOXO1 ORC1 NCOA3 NCOA6 ARID1B GTF2H1 NCOA1 MLLT6 CHD7 CREBBP EP300 | 1.07e-06 | 739 | 48 | 11 | GO:0003682 |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 1.20e-06 | 78 | 48 | 5 | GO:0008080 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | BCL9L NCOA3 NCOA6 ARID1B KMT2D SGTA MED8 NCOA1 MAML2 BCL9 SS18 CREBBP CNOT2 EP300 | 2.24e-06 | 1356 | 48 | 14 | GO:0060090 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | BCL9L NCOA3 NCOA6 ARID1B KMT2D MED8 NCOA1 MAML2 BCL9 SS18 CREBBP CNOT2 EP300 | 2.30e-06 | 1160 | 48 | 13 | GO:0030674 |
| GeneOntologyMolecularFunction | N-acyltransferase activity | 4.53e-06 | 102 | 48 | 5 | GO:0016410 | |
| GeneOntologyMolecularFunction | acetyltransferase activity | 4.99e-06 | 104 | 48 | 5 | GO:0016407 | |
| GeneOntologyMolecularFunction | carbamoyl-phosphate synthase (ammonia) activity | 5.66e-06 | 2 | 48 | 2 | GO:0004087 | |
| GeneOntologyMolecularFunction | carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity | 5.66e-06 | 2 | 48 | 2 | GO:0004088 | |
| GeneOntologyMolecularFunction | peptide lactyltransferase (CoA-dependent) activity | 5.66e-06 | 2 | 48 | 2 | GO:0120300 | |
| GeneOntologyMolecularFunction | histone H3K27 acetyltransferase activity | 5.66e-06 | 2 | 48 | 2 | GO:0044017 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 6.76e-06 | 51 | 48 | 4 | GO:0004402 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 9.16e-06 | 55 | 48 | 4 | GO:0061733 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 1.30e-05 | 60 | 48 | 4 | GO:0034212 | |
| GeneOntologyMolecularFunction | nuclear receptor coactivator activity | 1.39e-05 | 61 | 48 | 4 | GO:0030374 | |
| GeneOntologyMolecularFunction | histone H3K18 acetyltransferase activity | 1.69e-05 | 3 | 48 | 2 | GO:0043993 | |
| GeneOntologyMolecularFunction | transcription factor binding | 6.58e-05 | 753 | 48 | 9 | GO:0008134 | |
| GeneOntologyMolecularFunction | nuclear thyroid hormone receptor binding | 7.40e-05 | 34 | 48 | 3 | GO:0046966 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 8.43e-05 | 187 | 48 | 5 | GO:0016922 | |
| GeneOntologyMolecularFunction | bHLH transcription factor binding | 9.56e-05 | 37 | 48 | 3 | GO:0043425 | |
| GeneOntologyMolecularFunction | beta-catenin binding | 1.97e-04 | 120 | 48 | 4 | GO:0008013 | |
| GeneOntologyMolecularFunction | histone modifying activity | 2.18e-04 | 229 | 48 | 5 | GO:0140993 | |
| GeneOntologyMolecularFunction | carbon-nitrogen ligase activity, with glutamine as amido-N-donor | 2.52e-04 | 10 | 48 | 2 | GO:0016884 | |
| GeneOntologyMolecularFunction | acyltransferase activity, transferring groups other than amino-acyl groups | 2.60e-04 | 238 | 48 | 5 | GO:0016747 | |
| GeneOntologyMolecularFunction | nuclear estrogen receptor binding | 2.81e-04 | 53 | 48 | 3 | GO:0030331 | |
| GeneOntologyMolecularFunction | transcription coactivator binding | 2.97e-04 | 54 | 48 | 3 | GO:0001223 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 3.55e-04 | 140 | 48 | 4 | GO:0001221 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 4.50e-04 | 582 | 48 | 7 | GO:0140297 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 4.68e-04 | 417 | 48 | 6 | GO:0061629 | |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 5.82e-04 | 15 | 48 | 2 | GO:0010484 | |
| GeneOntologyMolecularFunction | nuclear glucocorticoid receptor binding | 1.05e-03 | 20 | 48 | 2 | GO:0035259 | |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 1.05e-03 | 83 | 48 | 3 | GO:1990841 | |
| GeneOntologyMolecularFunction | SMAD binding | 1.16e-03 | 86 | 48 | 3 | GO:0046332 | |
| GeneOntologyMolecularFunction | nuclear retinoid X receptor binding | 1.39e-03 | 23 | 48 | 2 | GO:0046965 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2.12e-03 | 1459 | 48 | 10 | GO:0000977 | |
| GeneOntologyMolecularFunction | nuclear androgen receptor binding | 2.85e-03 | 33 | 48 | 2 | GO:0050681 | |
| GeneOntologyMolecularFunction | disordered domain specific binding | 3.96e-03 | 39 | 48 | 2 | GO:0097718 | |
| GeneOntologyMolecularFunction | protein phosphatase 2A binding | 4.58e-03 | 42 | 48 | 2 | GO:0051721 | |
| GeneOntologyMolecularFunction | ligase activity, forming carbon-nitrogen bonds | 7.21e-03 | 53 | 48 | 2 | GO:0016879 | |
| GeneOntologyMolecularFunction | chromatin DNA binding | 7.54e-03 | 167 | 48 | 3 | GO:0031490 | |
| GeneOntologyMolecularFunction | nuclear retinoic acid receptor binding | 7.75e-03 | 55 | 48 | 2 | GO:0042974 | |
| GeneOntologyMolecularFunction | acyltransferase activity | 1.03e-02 | 775 | 48 | 6 | GO:0016746 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 1.08e-02 | 560 | 48 | 5 | GO:0001228 | |
| GeneOntologyMolecularFunction | basal RNA polymerase II transcription machinery binding | 1.10e-02 | 66 | 48 | 2 | GO:0001099 | |
| GeneOntologyMolecularFunction | basal transcription machinery binding | 1.10e-02 | 66 | 48 | 2 | GO:0001098 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 1.13e-02 | 566 | 48 | 5 | GO:0001216 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | FOXO1 BCL9L NCOA3 NCOA6 KMT2D TCF12 MED8 NCOA1 SHOX MLLT6 CHD7 MAML2 BCL9 IKBKB EFCAB7 SS18 CREBBP EP300 | 7.71e-10 | 1390 | 48 | 18 | GO:0045944 |
| GeneOntologyBiologicalProcess | response to hormone | FOXO1 NCOA3 NCOA6 ZNF536 ARID1B GTF2H1 KMT2D CAD TCF12 NCOA1 CPS1 IKBKB CNOT2 EP300 | 6.22e-08 | 1042 | 48 | 14 | GO:0009725 |
| GeneOntologyBiologicalProcess | stem cell population maintenance | 1.19e-06 | 237 | 48 | 7 | GO:0019827 | |
| GeneOntologyBiologicalProcess | maintenance of cell number | 1.37e-06 | 242 | 48 | 7 | GO:0098727 | |
| GeneOntologyBiologicalProcess | hormone-mediated signaling pathway | 1.45e-06 | 244 | 48 | 7 | GO:0009755 | |
| GeneOntologyBiologicalProcess | response to nitrogen compound | FOXO1 CACNA1B ARID1B CAD TCF12 SGTA NCOA1 RGS9 CPS1 IKBKB MYRF CREBBP EP300 | 4.45e-06 | 1272 | 48 | 13 | GO:1901698 |
| GeneOntologyBiologicalProcess | cellular response to hormone stimulus | FOXO1 NCOA3 ZNF536 ARID1B GTF2H1 KMT2D NCOA1 CPS1 CNOT2 EP300 | 5.41e-06 | 727 | 48 | 10 | GO:0032870 |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated signaling pathway | 7.14e-06 | 202 | 48 | 6 | GO:0141193 | |
| GeneOntologyBiologicalProcess | DNA-templated transcription initiation | 1.53e-05 | 231 | 48 | 6 | GO:0006352 | |
| GeneOntologyBiologicalProcess | stimulatory C-type lectin receptor signaling pathway | 2.03e-05 | 23 | 48 | 3 | GO:0002223 | |
| GeneOntologyBiologicalProcess | cellular response to lectin | 2.03e-05 | 23 | 48 | 3 | GO:1990858 | |
| GeneOntologyBiologicalProcess | response to lectin | 2.03e-05 | 23 | 48 | 3 | GO:1990840 | |
| GeneOntologyBiologicalProcess | response to organic cyclic compound | CACNA1B NCOA3 KMT2D CAD NCOA1 RGS9 CPS1 MYRF CREBBP CNOT2 EP300 | 2.21e-05 | 1048 | 48 | 11 | GO:0014070 |
| GeneOntologyBiologicalProcess | response to steroid hormone | 2.66e-05 | 381 | 48 | 7 | GO:0048545 | |
| GeneOntologyBiologicalProcess | N-terminal peptidyl-lysine acetylation | 3.17e-05 | 4 | 48 | 2 | GO:0018076 | |
| GeneOntologyBiologicalProcess | intracellular receptor signaling pathway | 4.66e-05 | 416 | 48 | 7 | GO:0030522 | |
| GeneOntologyBiologicalProcess | regulation of intracellular steroid hormone receptor signaling pathway | 4.99e-05 | 87 | 48 | 4 | GO:0033143 | |
| GeneOntologyBiologicalProcess | citrulline biosynthetic process | 5.28e-05 | 5 | 48 | 2 | GO:0019240 | |
| GeneOntologyBiologicalProcess | transcription initiation at RNA polymerase II promoter | 7.07e-05 | 186 | 48 | 5 | GO:0006367 | |
| GeneOntologyBiologicalProcess | 'de novo' pyrimidine nucleobase biosynthetic process | 7.91e-05 | 6 | 48 | 2 | GO:0006207 | |
| GeneOntologyBiologicalProcess | regulation of intracellular estrogen receptor signaling pathway | 8.00e-05 | 36 | 48 | 3 | GO:0033146 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | 8.27e-05 | 999 | 48 | 10 | GO:0071824 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleobase biosynthetic process | 1.47e-04 | 8 | 48 | 2 | GO:0019856 | |
| GeneOntologyBiologicalProcess | citrulline metabolic process | 1.89e-04 | 9 | 48 | 2 | GO:0000052 | |
| GeneOntologyBiologicalProcess | chromatin organization | 1.93e-04 | 896 | 48 | 9 | GO:0006325 | |
| GeneOntologyBiologicalProcess | response to peptide hormone | 2.10e-04 | 530 | 48 | 7 | GO:0043434 | |
| GeneOntologyBiologicalProcess | response to lipid | 2.21e-04 | 1126 | 48 | 10 | GO:0033993 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated steroid hormone signaling pathway | 2.81e-04 | 136 | 48 | 4 | GO:0030518 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | 2.82e-04 | 741 | 48 | 8 | GO:0006338 | |
| GeneOntologyBiologicalProcess | response to ketone | 3.03e-04 | 254 | 48 | 5 | GO:1901654 | |
| GeneOntologyBiologicalProcess | estrogen receptor signaling pathway | 3.17e-04 | 57 | 48 | 3 | GO:0030520 | |
| GeneOntologyBiologicalProcess | response to amine | 3.34e-04 | 58 | 48 | 3 | GO:0014075 | |
| GeneOntologyBiologicalProcess | positive regulation of intracellular estrogen receptor signaling pathway | 3.45e-04 | 12 | 48 | 2 | GO:0033148 | |
| GeneOntologyBiologicalProcess | face development | 4.26e-04 | 63 | 48 | 3 | GO:0060324 | |
| GeneOntologyBiologicalProcess | labyrinthine layer development | 4.46e-04 | 64 | 48 | 3 | GO:0060711 | |
| GeneOntologyBiologicalProcess | steroid hormone receptor signaling pathway | 4.62e-04 | 155 | 48 | 4 | GO:0043401 | |
| GeneOntologyBiologicalProcess | protein acetylation | 5.33e-04 | 68 | 48 | 3 | GO:0006473 | |
| GeneOntologyBiologicalProcess | N-terminal protein amino acid acetylation | 6.23e-04 | 16 | 48 | 2 | GO:0006474 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to heat | 6.23e-04 | 16 | 48 | 2 | GO:1900034 | |
| GeneOntologyBiologicalProcess | non-proteinogenic amino acid biosynthetic process | 7.05e-04 | 17 | 48 | 2 | GO:0170043 | |
| GeneOntologyBiologicalProcess | positive regulation of intracellular steroid hormone receptor signaling pathway | 7.92e-04 | 18 | 48 | 2 | GO:0033145 | |
| GeneOntologyBiologicalProcess | nucleobase biosynthetic process | 7.92e-04 | 18 | 48 | 2 | GO:0046112 | |
| GeneOntologyBiologicalProcess | regulation of stem cell population maintenance | 7.96e-04 | 78 | 48 | 3 | GO:2000036 | |
| GeneOntologyBiologicalProcess | regulation of metal ion transport | 9.48e-04 | 493 | 48 | 6 | GO:0010959 | |
| GeneOntologyBiologicalProcess | regulation of transforming growth factor beta receptor signaling pathway | 1.03e-03 | 192 | 48 | 4 | GO:0017015 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | 1.06e-03 | 906 | 48 | 8 | GO:0043009 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to transforming growth factor beta stimulus | 1.09e-03 | 195 | 48 | 4 | GO:1903844 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleobase metabolic process | 1.19e-03 | 22 | 48 | 2 | GO:0006206 | |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | 1.25e-03 | 929 | 48 | 8 | GO:0009792 | |
| GeneOntologyCellularComponent | transcription regulator complex | BCL9L NCOA3 NCOA6 GTF2H1 TCF12 DACH2 MED8 NCOA1 BCL9 CREBBP EP300 | 6.33e-08 | 596 | 47 | 11 | GO:0005667 |
| GeneOntologyCellularComponent | RNA polymerase II transcription regulator complex | 1.50e-07 | 272 | 47 | 8 | GO:0090575 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | ORC1 BCL9L NCOA3 NCOA6 ARID1B GTF2H1 KMT2D TCF12 NUP155 MED8 TMOD1 NCOA1 BCL9 SS18 CREBBP | 1.79e-07 | 1377 | 47 | 15 | GO:0140513 |
| GeneOntologyCellularComponent | MLL3/4 complex | 3.22e-04 | 12 | 47 | 2 | GO:0044666 | |
| GeneOntologyCellularComponent | beta-catenin-TCF complex | 3.80e-04 | 13 | 47 | 2 | GO:1990907 | |
| GeneOntologyCellularComponent | npBAF complex | 4.43e-04 | 14 | 47 | 2 | GO:0071564 | |
| GeneOntologyCellularComponent | chromatin | 1.42e-03 | 1480 | 47 | 10 | GO:0000785 | |
| GeneOntologyCellularComponent | SWI/SNF complex | 2.07e-03 | 30 | 47 | 2 | GO:0016514 | |
| HumanPheno | Elbow dislocation | 5.41e-07 | 84 | 20 | 6 | HP:0003042 | |
| HumanPheno | Upper extremity joint dislocation | 1.20e-06 | 96 | 20 | 6 | HP:0030310 | |
| HumanPheno | Dislocated radial head | 1.52e-06 | 54 | 20 | 5 | HP:0003083 | |
| HumanPheno | Abnormality of the radial head | 2.00e-06 | 57 | 20 | 5 | HP:0003995 | |
| HumanPheno | Abnormality of the humeroradial joint | 3.06e-06 | 62 | 20 | 5 | HP:0100744 | |
| HumanPheno | Pilomatrixoma | 4.28e-06 | 9 | 20 | 3 | HP:0030434 | |
| HumanPheno | Long eyelashes | 6.80e-06 | 129 | 20 | 6 | HP:0000527 | |
| HumanPheno | Plantar crease between first and second toes | 1.46e-05 | 2 | 20 | 2 | HP:0008107 | |
| HumanPheno | Aortic isthmus hypoplasia | 1.46e-05 | 2 | 20 | 2 | HP:0034227 | |
| HumanPheno | High axial triradius | 1.46e-05 | 2 | 20 | 2 | HP:0001042 | |
| HumanPheno | Prominent fingertip pads | 2.54e-05 | 46 | 20 | 4 | HP:0001212 | |
| HumanPheno | Square face | 2.81e-05 | 16 | 20 | 3 | HP:0000321 | |
| HumanPheno | Prominent digit pad | 3.01e-05 | 48 | 20 | 4 | HP:0011298 | |
| HumanPheno | Hypoplastic left heart | 3.27e-05 | 49 | 20 | 4 | HP:0004383 | |
| HumanPheno | Premature thelarche | 3.40e-05 | 17 | 20 | 3 | HP:0010314 | |
| HumanPheno | Congenital malformation of the left heart | 3.84e-05 | 51 | 20 | 4 | HP:0045017 | |
| HumanPheno | Skin appendage neoplasm | 4.07e-05 | 18 | 20 | 3 | HP:0012842 | |
| HumanPheno | Laryngeal cartilage malformation | 4.38e-05 | 3 | 20 | 2 | HP:0008752 | |
| HumanPheno | Phobia | 4.38e-05 | 3 | 20 | 2 | HP:5200232 | |
| HumanPheno | Agoraphobia | 4.38e-05 | 3 | 20 | 2 | HP:0000756 | |
| HumanPheno | Humoral immunodeficiency | 4.38e-05 | 3 | 20 | 2 | HP:0005363 | |
| HumanPheno | Prominent nasal septum | 4.38e-05 | 3 | 20 | 2 | HP:0005322 | |
| HumanPheno | Radial deviation of thumb terminal phalanx | 4.38e-05 | 3 | 20 | 2 | HP:0005895 | |
| HumanPheno | Hypoplastic heart | 4.82e-05 | 54 | 20 | 4 | HP:0001961 | |
| HumanPheno | Abnormal patella morphology | 4.91e-05 | 109 | 20 | 5 | HP:0003045 | |
| HumanPheno | Abnormal aortic arch morphology | 4.91e-05 | 109 | 20 | 5 | HP:0012303 | |
| HumanPheno | Localized hirsutism | 6.58e-05 | 21 | 20 | 3 | HP:0009889 | |
| HumanPheno | Interrupted aortic arch | 7.60e-05 | 22 | 20 | 3 | HP:0011611 | |
| HumanPheno | Trichiasis | 8.75e-05 | 4 | 20 | 2 | HP:0001128 | |
| HumanPheno | Visceral hemangioma | 8.75e-05 | 4 | 20 | 2 | HP:0410266 | |
| HumanPheno | Talon cusp | 8.75e-05 | 4 | 20 | 2 | HP:0011087 | |
| HumanPheno | Widened distal phalanges | 8.75e-05 | 4 | 20 | 2 | HP:0006200 | |
| HumanPheno | Dysplastic tricuspid valve | 8.75e-05 | 4 | 20 | 2 | HP:0030732 | |
| HumanPheno | Scimitar anomaly | 8.75e-05 | 4 | 20 | 2 | HP:0011626 | |
| HumanPheno | Vascular ring | 8.75e-05 | 4 | 20 | 2 | HP:0010775 | |
| HumanPheno | Hepatic hemangioma | 8.75e-05 | 4 | 20 | 2 | HP:0031207 | |
| HumanPheno | Clinodactyly of the 5th finger | 1.04e-04 | 420 | 20 | 8 | HP:0004209 | |
| HumanPheno | Clinodactyly of hands | 1.05e-04 | 421 | 20 | 8 | HP:0001157 | |
| HumanPheno | Deviation of the 5th finger | 1.05e-04 | 421 | 20 | 8 | HP:0009179 | |
| HumanPheno | Shawl scrotum | 1.13e-04 | 25 | 20 | 3 | HP:0000049 | |
| HumanPheno | Papillary cystadenoma of the epididymis | 1.45e-04 | 5 | 20 | 2 | HP:0009715 | |
| HumanPheno | Supernumerary cusp | 1.45e-04 | 5 | 20 | 2 | HP:0033777 | |
| HumanPheno | Epididymal neoplasm | 1.45e-04 | 5 | 20 | 2 | HP:0030421 | |
| HumanPheno | Radial deviation of finger | 1.64e-04 | 448 | 20 | 8 | HP:0009466 | |
| HumanPheno | Finger clinodactyly | 1.74e-04 | 452 | 20 | 8 | HP:0040019 | |
| HumanPheno | Short columella | 1.77e-04 | 29 | 20 | 3 | HP:0002000 | |
| HumanPheno | Abnormal scrotum morphology | 1.79e-04 | 143 | 20 | 5 | HP:0000045 | |
| HumanPheno | Radial deviation of the hand or of fingers of the hand | 1.86e-04 | 456 | 20 | 8 | HP:0009485 | |
| HumanPheno | Large foramen magnum | 2.18e-04 | 6 | 20 | 2 | HP:0002700 | |
| HumanPheno | Aplasia/Hypoplasia of the patella | 2.62e-04 | 33 | 20 | 3 | HP:0006498 | |
| HumanPheno | Abnormal branching pattern of the aortic arch | 2.62e-04 | 33 | 20 | 3 | HP:0011587 | |
| HumanPheno | Intestinal malrotation | 2.78e-04 | 157 | 20 | 5 | HP:0002566 | |
| HumanPheno | Supernumerary tooth | 2.85e-04 | 85 | 20 | 4 | HP:0011069 | |
| HumanPheno | Deviated nasal septum | 3.04e-04 | 7 | 20 | 2 | HP:0004411 | |
| HumanPheno | Hydrocele testis | 3.40e-04 | 36 | 20 | 3 | HP:0000034 | |
| HumanPheno | Nasolacrimal duct obstruction | 3.40e-04 | 36 | 20 | 3 | HP:0000579 | |
| HumanPheno | Accessory spleen | 3.69e-04 | 37 | 20 | 3 | HP:0001747 | |
| HumanPheno | Hypospadias | 3.83e-04 | 377 | 20 | 7 | HP:0000047 | |
| HumanPheno | Abnormal palmar dermatoglyphics | 3.91e-04 | 265 | 20 | 6 | HP:0001018 | |
| HumanPheno | Abnormal 5th finger morphology | 3.99e-04 | 509 | 20 | 8 | HP:0004207 | |
| HumanPheno | Natal tooth | 4.00e-04 | 38 | 20 | 3 | HP:0000695 | |
| HumanPheno | Joint dislocation | 4.71e-04 | 390 | 20 | 7 | HP:0001373 | |
| HumanPheno | Cervical cord compression | 5.19e-04 | 9 | 20 | 2 | HP:0002341 | |
| HumanPheno | Displacement of the urethral meatus | 5.26e-04 | 397 | 20 | 7 | HP:0100627 | |
| HumanPheno | Abnormal male urethral meatus morphology | 5.42e-04 | 399 | 20 | 7 | HP:0032076 | |
| HumanPheno | Abnormality of the elbow | 5.47e-04 | 282 | 20 | 6 | HP:0009811 | |
| HumanPheno | Abnormal eyelash morphology | 5.68e-04 | 284 | 20 | 6 | HP:0000499 | |
| HumanPheno | Deviation of finger | 5.77e-04 | 537 | 20 | 8 | HP:0004097 | |
| HumanPheno | Juvenile aseptic necrosis | 5.78e-04 | 43 | 20 | 3 | HP:0100323 | |
| HumanPheno | Aplasia/hypoplasia involving bones of the hand | 5.84e-04 | 538 | 20 | 8 | HP:0005927 | |
| HumanPheno | Frontal hirsutism | 6.47e-04 | 10 | 20 | 2 | HP:0011335 | |
| HumanPheno | Advanced eruption of teeth | 7.06e-04 | 46 | 20 | 3 | HP:0006288 | |
| HumanPheno | Abnormal dental morphology | 7.47e-04 | 299 | 20 | 6 | HP:0006482 | |
| HumanPheno | Partial anomalous pulmonary venous return | 7.89e-04 | 11 | 20 | 2 | HP:0010773 | |
| HumanPheno | Abnormal subclavian artery morphology | 7.89e-04 | 11 | 20 | 2 | HP:0031251 | |
| HumanPheno | Chiari type I malformation | 8.00e-04 | 48 | 20 | 3 | HP:0007099 | |
| HumanPheno | Deviation of the hand or of fingers of the hand | 8.05e-04 | 564 | 20 | 8 | HP:0009484 | |
| HumanPheno | Abnormal femur morphology | 8.16e-04 | 304 | 20 | 6 | HP:0002823 | |
| HumanPheno | Abnormal femoral neck/head morphology | 8.69e-04 | 201 | 20 | 5 | HP:0003366 | |
| HumanPheno | Abnormal toe morphology | 8.82e-04 | 893 | 20 | 10 | HP:0001780 | |
| HumanPheno | Aplasia/hypoplasia involving bones of the upper limbs | 8.85e-04 | 572 | 20 | 8 | HP:0006496 | |
| HumanPheno | Abnormal lacrimal duct morphology | 9.02e-04 | 50 | 20 | 3 | HP:0011481 | |
| HumanPheno | Clinodactyly | 9.07e-04 | 574 | 20 | 8 | HP:0030084 | |
| HumanPheno | Duodenal ulcer | 9.44e-04 | 12 | 20 | 2 | HP:0002588 | |
| HumanPheno | Hypoplasia of the phalanges of the toes | 9.44e-04 | 12 | 20 | 2 | HP:0010746 | |
| HumanPheno | Self-mutilation | 9.56e-04 | 51 | 20 | 3 | HP:0000742 | |
| HumanPheno | Abnormal dermatoglyphics | 9.69e-04 | 314 | 20 | 6 | HP:0007477 | |
| HumanPheno | Aplasia/Hypoplasia of the earlobes | 1.07e-03 | 53 | 20 | 3 | HP:0009906 | |
| HumanPheno | Abnormality of the thigh | 1.11e-03 | 322 | 20 | 6 | HP:0001439 | |
| HumanPheno | Facial grimacing | 1.11e-03 | 13 | 20 | 2 | HP:0000273 | |
| HumanPheno | Keloids | 1.11e-03 | 13 | 20 | 2 | HP:0010562 | |
| HumanPheno | Short finger | 1.16e-03 | 325 | 20 | 6 | HP:0009381 | |
| HumanPheno | Single transverse palmar crease | 1.18e-03 | 215 | 20 | 5 | HP:0000954 | |
| HumanPheno | Hirsutism | 1.20e-03 | 216 | 20 | 5 | HP:0001007 | |
| HumanPheno | Abnormal morphology of the radius | 1.23e-03 | 217 | 20 | 5 | HP:0002818 | |
| HumanPheno | Low hanging columella | 1.26e-03 | 56 | 20 | 3 | HP:0009765 | |
| HumanPheno | Duplication of phalanx of hallux | 1.30e-03 | 14 | 20 | 2 | HP:0010066 | |
| HumanPheno | Hypoplastic aortic arch | 1.30e-03 | 14 | 20 | 2 | HP:0012304 | |
| HumanPheno | Parietal foramina | 1.30e-03 | 14 | 20 | 2 | HP:0002697 | |
| HumanPheno | Abnormality of the urethra | 1.36e-03 | 465 | 20 | 7 | HP:0000795 | |
| MousePheno | decreased circulating glucagon level | 1.89e-05 | 20 | 37 | 3 | MP:0002696 | |
| MousePheno | abnormal hypothalamus physiology | 4.26e-05 | 26 | 37 | 3 | MP:0005645 | |
| MousePheno | embryonic lethality during organogenesis, complete penetrance | 6.60e-05 | 700 | 37 | 9 | MP:0011098 | |
| MousePheno | thin myocardium | 7.22e-05 | 85 | 37 | 4 | MP:0002652 | |
| MousePheno | abnormal embryonic growth/weight/body size | FOXO1 BCL9L NCOA3 NCOA6 RBM12 TMOD1 CHD7 BCL9 SS18 MYRF CREBBP EP300 | 7.83e-05 | 1295 | 37 | 12 | MP:0002088 |
| MousePheno | embryonic growth retardation | 1.28e-04 | 763 | 37 | 9 | MP:0003984 | |
| MousePheno | abnormal circulating glucagon level | 1.58e-04 | 40 | 37 | 3 | MP:0002695 | |
| MousePheno | absent organized vascular network | 1.89e-04 | 8 | 37 | 2 | MP:0000263 | |
| MousePheno | pericardial effusion | 2.03e-04 | 111 | 37 | 4 | MP:0005312 | |
| MousePheno | thin myocardium compact layer | 2.40e-04 | 46 | 37 | 3 | MP:0004057 | |
| MousePheno | decreased circulating free fatty acids level | 2.41e-04 | 116 | 37 | 4 | MP:0002702 | |
| MousePheno | embryonic growth arrest | 2.68e-04 | 346 | 37 | 6 | MP:0001730 | |
| MousePheno | open neural tube | 3.02e-04 | 226 | 37 | 5 | MP:0000929 | |
| MousePheno | abnormal prenatal growth/weight/body size | FOXO1 BCL9L NCOA3 NCOA6 RBM12 TMOD1 CHD7 BCL9 SS18 MYRF CREBBP EP300 | 3.05e-04 | 1493 | 37 | 12 | MP:0004196 |
| MousePheno | prenatal growth retardation | 3.41e-04 | 869 | 37 | 9 | MP:0010865 | |
| MousePheno | embryonic lethality during organogenesis | 3.61e-04 | 876 | 37 | 9 | MP:0006207 | |
| MousePheno | abnormal vitelline vasculature morphology | 3.62e-04 | 235 | 37 | 5 | MP:0003229 | |
| MousePheno | abnormal vasculogenesis | 3.86e-04 | 54 | 37 | 3 | MP:0001622 | |
| MousePheno | abnormal heart development | 3.94e-04 | 372 | 37 | 6 | MP:0000267 | |
| MousePheno | flattened snout | 4.42e-04 | 12 | 37 | 2 | MP:0000447 | |
| MousePheno | decreased circulating hormone level | 5.23e-04 | 551 | 37 | 7 | MP:0014457 | |
| MousePheno | abnormal myocardial trabeculae morphology | 5.48e-04 | 144 | 37 | 4 | MP:0002189 | |
| MousePheno | decreased circulating insulin-like growth factor I level | 5.53e-04 | 61 | 37 | 3 | MP:0004701 | |
| MousePheno | abnormal embryo development | FOXO1 BCL9L NCOA6 RBM12 NUP155 TMOD1 CHD7 SS18 MYRF CREBBP EP300 | 5.95e-04 | 1370 | 37 | 11 | MP:0001672 |
| MousePheno | decreased fatty acids level | 6.55e-04 | 151 | 37 | 4 | MP:0005282 | |
| MousePheno | effusion | 6.71e-04 | 152 | 37 | 4 | MP:0021205 | |
| MousePheno | abnormal fibroblast physiology | 6.92e-04 | 271 | 37 | 5 | MP:0020414 | |
| MousePheno | abnormal myocardium layer morphology | 6.94e-04 | 414 | 37 | 6 | MP:0005329 | |
| MousePheno | abnormal chorionic plate morphology | 7.00e-04 | 15 | 37 | 2 | MP:0004560 | |
| MousePheno | abnormal myocardium compact layer morphology | 7.28e-04 | 67 | 37 | 3 | MP:0004056 | |
| MousePheno | abnormal carbon dioxide production | 7.28e-04 | 67 | 37 | 3 | MP:0008962 | |
| MousePheno | abnormal heart layer morphology | 7.67e-04 | 422 | 37 | 6 | MP:0010545 | |
| MousePheno | decreased susceptibility to diet-induced obesity | 8.13e-04 | 160 | 37 | 4 | MP:0005659 | |
| MousePheno | ventricle myocardium hypoplasia | 8.62e-04 | 71 | 37 | 3 | MP:0010502 | |
| MousePheno | abnormal gas homeostasis | 8.67e-04 | 600 | 37 | 7 | MP:0003948 | |
| MousePheno | abnormal circulating insulin-like growth factor I level | 8.98e-04 | 72 | 37 | 3 | MP:0004700 | |
| MousePheno | absent olfactory bulb | 9.04e-04 | 17 | 37 | 2 | MP:0003451 | |
| MousePheno | abnormal epicardium morphology | 9.04e-04 | 17 | 37 | 2 | MP:0003057 | |
| MousePheno | increased grooming behavior | 9.72e-04 | 74 | 37 | 3 | MP:0001441 | |
| MousePheno | abnormal insulin-like growth factor I level | 1.01e-03 | 75 | 37 | 3 | MP:0008831 | |
| MousePheno | decreased fetal cardiomyocyte proliferation | 1.02e-03 | 18 | 37 | 2 | MP:0011395 | |
| MousePheno | hypoalgesia | 1.02e-03 | 170 | 37 | 4 | MP:0003043 | |
| MousePheno | decreased hormone level | 1.21e-03 | 635 | 37 | 7 | MP:0014455 | |
| MousePheno | abnormal nervous system development | NCOA6 CELSR1 ARID1B RBM12 TCF12 NCOA1 CHD7 SS18 CREBBP EP300 | 1.21e-03 | 1257 | 37 | 10 | MP:0003861 |
| MousePheno | abnormal susceptibility to weight gain | 1.25e-03 | 309 | 37 | 5 | MP:0011117 | |
| MousePheno | thin ventricle myocardium compact layer | 1.26e-03 | 20 | 37 | 2 | MP:0010556 | |
| MousePheno | abnormal liver glycogen level | 1.26e-03 | 81 | 37 | 3 | MP:0012777 | |
| MousePheno | abnormal energy expenditure | 1.32e-03 | 313 | 37 | 5 | MP:0005450 | |
| MousePheno | decreased susceptibility to weight gain | 1.42e-03 | 186 | 37 | 4 | MP:0010182 | |
| MousePheno | abnormal energy homeostasis | 1.50e-03 | 322 | 37 | 5 | MP:0005448 | |
| MousePheno | myocardium hypoplasia | 1.50e-03 | 86 | 37 | 3 | MP:0010500 | |
| MousePheno | head shaking | 1.52e-03 | 22 | 37 | 2 | MP:0002730 | |
| MousePheno | absent myocardial trabeculae | 1.52e-03 | 22 | 37 | 2 | MP:0000293 | |
| Domain | Nuc_rcpt_coact | 5.74e-10 | 6 | 48 | 4 | IPR009110 | |
| Domain | CPSase_sm_chain | 6.47e-06 | 2 | 48 | 2 | PF00988 | |
| Domain | BCL9_beta-catenin-bd_dom | 6.47e-06 | 2 | 48 | 2 | IPR024670 | |
| Domain | Nuc_rcpt_coact_CREBbp | 6.47e-06 | 2 | 48 | 2 | IPR014744 | |
| Domain | HAT_KAT11 | 6.47e-06 | 2 | 48 | 2 | PF08214 | |
| Domain | KIX | 6.47e-06 | 2 | 48 | 2 | PS50952 | |
| Domain | BCL9 | 6.47e-06 | 2 | 48 | 2 | PF11502 | |
| Domain | ZnF_TAZ | 6.47e-06 | 2 | 48 | 2 | SM00551 | |
| Domain | CBP_P300_HAT | 6.47e-06 | 2 | 48 | 2 | IPR031162 | |
| Domain | DUF902 | 6.47e-06 | 2 | 48 | 2 | PF06001 | |
| Domain | CPSase_L_D3 | 6.47e-06 | 2 | 48 | 2 | PF02787 | |
| Domain | - | 6.47e-06 | 2 | 48 | 2 | 1.20.1020.10 | |
| Domain | RING_CBP-p300 | 6.47e-06 | 2 | 48 | 2 | IPR010303 | |
| Domain | - | 6.47e-06 | 2 | 48 | 2 | 1.10.1630.10 | |
| Domain | Creb_binding | 6.47e-06 | 2 | 48 | 2 | PF09030 | |
| Domain | CarbamoylP_synth_ssu | 6.47e-06 | 2 | 48 | 2 | IPR006274 | |
| Domain | CarbamoylP_synth_lsu | 6.47e-06 | 2 | 48 | 2 | IPR006275 | |
| Domain | - | 6.47e-06 | 2 | 48 | 2 | 1.10.246.20 | |
| Domain | zf-TAZ | 6.47e-06 | 2 | 48 | 2 | PF02135 | |
| Domain | - | 6.47e-06 | 2 | 48 | 2 | 3.50.30.20 | |
| Domain | ZF_TAZ | 6.47e-06 | 2 | 48 | 2 | PS50134 | |
| Domain | CPSase_sm_chain | 6.47e-06 | 2 | 48 | 2 | SM01097 | |
| Domain | CPSase_L_D3 | 6.47e-06 | 2 | 48 | 2 | SM01096 | |
| Domain | CbamoylP_synth_lsu_CPSase_dom | 6.47e-06 | 2 | 48 | 2 | IPR005483 | |
| Domain | CarbamoylP_synth_lsu_oligo | 6.47e-06 | 2 | 48 | 2 | IPR005480 | |
| Domain | Histone_AcTrfase_Rtt109/CBP | 6.47e-06 | 2 | 48 | 2 | IPR013178 | |
| Domain | - | 6.47e-06 | 2 | 48 | 2 | 1.10.1030.10 | |
| Domain | KAT11 | 6.47e-06 | 2 | 48 | 2 | SM01250 | |
| Domain | Znf_TAZ | 6.47e-06 | 2 | 48 | 2 | IPR000197 | |
| Domain | KIX_dom | 6.47e-06 | 2 | 48 | 2 | IPR003101 | |
| Domain | KIX | 6.47e-06 | 2 | 48 | 2 | PF02172 | |
| Domain | CarbamoylP_synth_ssu_N | 6.47e-06 | 2 | 48 | 2 | IPR002474 | |
| Domain | Bcl-9 | 6.47e-06 | 2 | 48 | 2 | IPR015668 | |
| Domain | CBP_P300_HAT | 6.47e-06 | 2 | 48 | 2 | PS51727 | |
| Domain | DUF1518 | 1.94e-05 | 3 | 48 | 2 | PF07469 | |
| Domain | DUF1518 | 1.94e-05 | 3 | 48 | 2 | IPR010011 | |
| Domain | Nuc_rcpt_coact_Ncoa-typ | 1.94e-05 | 3 | 48 | 2 | IPR014920 | |
| Domain | SRC-1 | 1.94e-05 | 3 | 48 | 2 | IPR014935 | |
| Domain | MGS | 1.94e-05 | 3 | 48 | 2 | SM00851 | |
| Domain | MGS-like_dom | 1.94e-05 | 3 | 48 | 2 | IPR011607 | |
| Domain | MGS | 1.94e-05 | 3 | 48 | 2 | PF02142 | |
| Domain | - | 1.94e-05 | 3 | 48 | 2 | 3.40.50.1380 | |
| Domain | Src1_rcpt_coact | 1.94e-05 | 3 | 48 | 2 | IPR008955 | |
| Domain | Nuclear_rcpt_coactivator | 1.94e-05 | 3 | 48 | 2 | IPR017426 | |
| Domain | DUF1518 | 1.94e-05 | 3 | 48 | 2 | SM01151 | |
| Domain | SRC-1 | 1.94e-05 | 3 | 48 | 2 | PF08832 | |
| Domain | - | 1.94e-05 | 3 | 48 | 2 | 4.10.630.10 | |
| Domain | Nuc_rec_co-act | 1.94e-05 | 3 | 48 | 2 | PF08815 | |
| Domain | GATase | 6.44e-05 | 5 | 48 | 2 | PF00117 | |
| Domain | CPSASE_1 | 6.44e-05 | 5 | 48 | 2 | PS00866 | |
| Domain | GATASE | 9.64e-05 | 6 | 48 | 2 | IPR017926 | |
| Domain | CPSASE_2 | 9.64e-05 | 6 | 48 | 2 | PS00867 | |
| Domain | GATASE_TYPE_1 | 9.64e-05 | 6 | 48 | 2 | PS51273 | |
| Domain | CPSase_L_D2 | 1.35e-04 | 7 | 48 | 2 | PF02786 | |
| Domain | CbamoylP_synth_lsu-like_ATP-bd | 1.35e-04 | 7 | 48 | 2 | IPR005479 | |
| Domain | BC-like_N | 1.35e-04 | 7 | 48 | 2 | IPR005481 | |
| Domain | Biotin_carb_N | 1.35e-04 | 7 | 48 | 2 | PF00289 | |
| Domain | - | 2.87e-04 | 10 | 48 | 2 | 3.40.50.880 | |
| Domain | Class_I_gatase-like | 4.20e-04 | 12 | 48 | 2 | IPR029062 | |
| Domain | - | 4.95e-04 | 13 | 48 | 2 | 3.40.50.20 | |
| Domain | ATP-grasp | 5.77e-04 | 14 | 48 | 2 | IPR011761 | |
| Domain | PreATP-grasp_dom | 5.77e-04 | 14 | 48 | 2 | IPR016185 | |
| Domain | ATP_GRASP | 5.77e-04 | 14 | 48 | 2 | PS50975 | |
| Domain | - | 6.65e-04 | 15 | 48 | 2 | 3.30.1490.20 | |
| Domain | ZZ | 9.64e-04 | 18 | 48 | 2 | PF00569 | |
| Domain | ATP_grasp_subdomain_1 | 9.64e-04 | 18 | 48 | 2 | IPR013815 | |
| Domain | ZF_ZZ_2 | 9.64e-04 | 18 | 48 | 2 | PS50135 | |
| Domain | ZF_ZZ_1 | 9.64e-04 | 18 | 48 | 2 | PS01357 | |
| Domain | - | 9.64e-04 | 18 | 48 | 2 | 3.30.470.20 | |
| Domain | Znf_ZZ | 1.08e-03 | 19 | 48 | 2 | IPR000433 | |
| Domain | ZnF_ZZ | 1.08e-03 | 19 | 48 | 2 | SM00291 | |
| Domain | EPHD | 1.45e-03 | 22 | 48 | 2 | PS51805 | |
| Domain | PAS | 1.87e-03 | 25 | 48 | 2 | PF00989 | |
| Domain | PAS_fold | 1.87e-03 | 25 | 48 | 2 | IPR013767 | |
| Domain | Bromodomain_CS | 2.02e-03 | 26 | 48 | 2 | IPR018359 | |
| Domain | - | 2.76e-03 | 109 | 48 | 3 | 4.10.280.10 | |
| Domain | ATP_grasp_subdomain_2 | 2.87e-03 | 31 | 48 | 2 | IPR013816 | |
| Domain | HLH | 2.91e-03 | 111 | 48 | 3 | PF00010 | |
| Domain | PAS | 3.05e-03 | 32 | 48 | 2 | SM00091 | |
| Domain | HLH | 3.29e-03 | 116 | 48 | 3 | SM00353 | |
| Domain | BHLH | 3.38e-03 | 117 | 48 | 3 | PS50888 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | 5.28e-08 | 84 | 35 | 6 | M1008 | |
| Pathway | REACTOME_RORA_ACTIVATES_GENE_EXPRESSION | 9.50e-08 | 18 | 35 | 4 | M26942 | |
| Pathway | REACTOME_ADIPOGENESIS | 2.66e-07 | 110 | 35 | 6 | M48259 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 4.03e-07 | 118 | 35 | 6 | M27316 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 4.58e-07 | 26 | 35 | 4 | MM14793 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 7.79e-07 | 8 | 35 | 3 | M22058 | |
| Pathway | PID_RETINOIC_ACID_PATHWAY | 8.33e-07 | 30 | 35 | 4 | M207 | |
| Pathway | REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION | 1.66e-06 | 10 | 35 | 3 | M27945 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 2.80e-06 | 91 | 35 | 5 | M27101 | |
| Pathway | WP_ANDROGEN_RECEPTOR_SIGNALING | 2.80e-06 | 91 | 35 | 5 | M39700 | |
| Pathway | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | 3.33e-06 | 42 | 35 | 4 | M17541 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 5.01e-06 | 14 | 35 | 3 | M27808 | |
| Pathway | PID_HES_HEY_PATHWAY | 5.73e-06 | 48 | 35 | 4 | M288 | |
| Pathway | REACTOME_HEME_SIGNALING | 6.23e-06 | 49 | 35 | 4 | M41832 | |
| Pathway | PID_FOXO_PATHWAY | 6.23e-06 | 49 | 35 | 4 | M136 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 6.25e-06 | 15 | 35 | 3 | MM1339 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 6.25e-06 | 15 | 35 | 3 | M10183 | |
| Pathway | WP_RUBINSTEINTAYBI_SYNDROME_1 | 6.25e-06 | 15 | 35 | 3 | M48323 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 7.68e-06 | 16 | 35 | 3 | M27121 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES | 7.68e-06 | 16 | 35 | 3 | M27940 | |
| Pathway | PID_AR_TF_PATHWAY | 8.55e-06 | 53 | 35 | 4 | M151 | |
| Pathway | REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS | 1.18e-05 | 122 | 35 | 5 | M29689 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 1.55e-05 | 20 | 35 | 3 | M27881 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | FOXO1 NCOA3 NCOA6 ARID1B KMT2D TCF12 MED8 NCOA1 MAML2 SS18 CREBBP CNOT2 EP300 | 2.01e-05 | 1432 | 35 | 13 | M509 |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION | 2.06e-05 | 66 | 35 | 4 | M27938 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 2.09e-05 | 22 | 35 | 3 | MM1370 | |
| Pathway | BIOCARTA_NTHI_PATHWAY | 2.09e-05 | 22 | 35 | 3 | MM1443 | |
| Pathway | BIOCARTA_NTHI_PATHWAY | 2.40e-05 | 23 | 35 | 3 | M2821 | |
| Pathway | REACTOME_CIRCADIAN_CLOCK | 2.60e-05 | 70 | 35 | 4 | M938 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 2.74e-05 | 24 | 35 | 3 | M13404 | |
| Pathway | REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 3.11e-05 | 25 | 35 | 3 | M27880 | |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | 3.38e-05 | 254 | 35 | 6 | M27131 | |
| Pathway | PID_HDAC_CLASSIII_PATHWAY | 3.51e-05 | 26 | 35 | 3 | M32 | |
| Pathway | WP_ESTROGEN_SIGNALING | 3.79e-05 | 77 | 35 | 4 | MM15934 | |
| Pathway | REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_GENE_EXPRESSION | 3.94e-05 | 27 | 35 | 3 | M26943 | |
| Pathway | PID_SMAD2_3NUCLEAR_PATHWAY | 4.85e-05 | 82 | 35 | 4 | M2 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 5.96e-05 | 5 | 35 | 2 | MM1575 | |
| Pathway | REACTOME_NFE2L2_REGULATING_INFLAMMATION_ASSOCIATED_GENES | 5.96e-05 | 5 | 35 | 2 | M48020 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ER_STRESS_ASSOCIATED_GENES | 5.96e-05 | 5 | 35 | 2 | M48023 | |
| Pathway | KEGG_MEDICUS_VARIANT_ESR1_POSITIVE_TO_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY | 5.96e-05 | 5 | 35 | 2 | M48983 | |
| Pathway | REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION | 5.96e-05 | 5 | 35 | 2 | M27228 | |
| Pathway | WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY | 6.01e-05 | 31 | 35 | 3 | M39476 | |
| Pathway | WP_PREGNANE_X_RECEPTOR_PATHWAY | 6.62e-05 | 32 | 35 | 3 | M39567 | |
| Pathway | KEGG_PROSTATE_CANCER | 6.69e-05 | 89 | 35 | 4 | M13191 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | FOXO1 ARID1B GTF2H1 KMT2D TCF12 ABCA6 MED8 MAML2 CREBBP GEM CNOT2 EP300 | 7.61e-05 | 1387 | 35 | 12 | M734 |
| Pathway | BIOCARTA_PELP1_PATHWAY | 8.93e-05 | 6 | 35 | 2 | M22062 | |
| Pathway | REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION | 8.93e-05 | 6 | 35 | 2 | MM15660 | |
| Pathway | WP_IL6_SIGNALING_PATHWAY | 1.05e-04 | 100 | 35 | 4 | MM15826 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 1.25e-04 | 7 | 35 | 2 | MM1573 | |
| Pathway | REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP | 1.51e-04 | 42 | 35 | 3 | M27172 | |
| Pathway | REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX | 1.51e-04 | 42 | 35 | 3 | M27272 | |
| Pathway | REACTOME_NFE2L2_REGULATING_MDR_ASSOCIATED_ENZYMES | 1.66e-04 | 8 | 35 | 2 | M48022 | |
| Pathway | REACTOME_REGULATION_OF_NFE2L2_GENE_EXPRESSION | 1.66e-04 | 8 | 35 | 2 | M48024 | |
| Pathway | REACTOME_NFE2L2_REGULATES_PENTOSE_PHOSPHATE_PATHWAY_GENES | 1.66e-04 | 8 | 35 | 2 | M46443 | |
| Pathway | PID_HNF3A_PATHWAY | 1.73e-04 | 44 | 35 | 3 | M285 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 1.73e-04 | 44 | 35 | 3 | M27295 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 2.11e-04 | 47 | 35 | 3 | M7946 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF3_SIGNALING_PATHWAY | 2.13e-04 | 9 | 35 | 2 | M47451 | |
| Pathway | WP_ENERGY_METABOLISM | 2.25e-04 | 48 | 35 | 3 | M39590 | |
| Pathway | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 2.25e-04 | 48 | 35 | 3 | M611 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 2.39e-04 | 49 | 35 | 3 | M618 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 2.56e-04 | 233 | 35 | 5 | M27099 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 2.66e-04 | 10 | 35 | 2 | MM15535 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 2.77e-04 | 237 | 35 | 5 | M27786 | |
| Pathway | BIOCARTA_PPARA_PATHWAY | 2.85e-04 | 52 | 35 | 3 | M2404 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 3.25e-04 | 11 | 35 | 2 | MM1521 | |
| Pathway | REACTOME_NFE2L2_REGULATING_TUMORIGENIC_GENES | 3.25e-04 | 11 | 35 | 2 | M48021 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR | 3.25e-04 | 11 | 35 | 2 | M26924 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY | 3.25e-04 | 11 | 35 | 2 | M47503 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS | 3.37e-04 | 55 | 35 | 3 | M27145 | |
| Pathway | REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF | 3.37e-04 | 55 | 35 | 3 | M27001 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 3.89e-04 | 12 | 35 | 2 | M7968 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS | 3.89e-04 | 12 | 35 | 2 | M27765 | |
| Pathway | REACTOME_NOTCH2_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 3.89e-04 | 12 | 35 | 2 | M27159 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER | 3.94e-04 | 58 | 35 | 3 | M29616 | |
| Pathway | REACTOME_CYTOPROTECTION_BY_HMOX1 | 4.35e-04 | 60 | 35 | 3 | M41830 | |
| Pathway | REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING | 4.59e-04 | 13 | 35 | 2 | MM15622 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | 4.86e-04 | 149 | 35 | 4 | M27888 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 5.21e-04 | 272 | 35 | 5 | M29619 | |
| Pathway | PID_ERA_GENOMIC_PATHWAY | 5.27e-04 | 64 | 35 | 3 | M200 | |
| Pathway | REACTOME_CYTOSOLIC_SENSORS_OF_PATHOGEN_ASSOCIATED_DNA | 5.27e-04 | 64 | 35 | 3 | M27046 | |
| Pathway | PID_HIF1_TFPATHWAY | 5.76e-04 | 66 | 35 | 3 | M255 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 6.07e-04 | 158 | 35 | 4 | MM14791 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 6.16e-04 | 15 | 35 | 2 | MM1439 | |
| Pathway | PID_ERB_GENOMIC_PATHWAY | 6.16e-04 | 15 | 35 | 2 | M119 | |
| Pathway | REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY | 6.16e-04 | 15 | 35 | 2 | M953 | |
| Pathway | WP_RAC1PAK1P38MMP2_PATHWAY | 6.29e-04 | 68 | 35 | 3 | M39456 | |
| Pathway | WP_UROTENSINIIMEDIATED_SIGNALING | 6.57e-04 | 69 | 35 | 3 | M48052 | |
| Pathway | REACTOME_FORMATION_OF_PARAXIAL_MESODERM | 6.57e-04 | 69 | 35 | 3 | M46439 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 7.03e-04 | 16 | 35 | 2 | M1296 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 7.03e-04 | 16 | 35 | 2 | MM1420 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 7.03e-04 | 16 | 35 | 2 | M8516 | |
| Pathway | PID_E2F_PATHWAY | 7.74e-04 | 73 | 35 | 3 | M40 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 7.96e-04 | 17 | 35 | 2 | MM1509 | |
| Pathway | REACTOME_ZYGOTIC_GENOME_ACTIVATION_ZGA | 7.96e-04 | 17 | 35 | 2 | M48025 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 8.05e-04 | 74 | 35 | 3 | M616 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | 8.24e-04 | 301 | 35 | 5 | MM15983 | |
| Pathway | WP_LEPTIN_SIGNALING | 8.71e-04 | 76 | 35 | 3 | M39491 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 8.94e-04 | 18 | 35 | 2 | MM14775 | |
| Pathway | PID_MYC_ACTIV_PATHWAY | 9.74e-04 | 79 | 35 | 3 | M66 | |
| Pubmed | BCL9L NCOA3 NCOA6 ARID1B KMT2D RBM12 MED8 NCOA1 CHD7 BCL9 CREBBP | 8.13e-14 | 268 | 48 | 11 | 33640491 | |
| Pubmed | BCL9L NCOA3 NCOA6 ZNF536 ARID1B KMT2D CAD RBM12 TCF12 MED8 NCOA1 MLLT6 CHD7 BCL9 SS18 CREBBP CNOT2 EP300 | 2.27e-13 | 1429 | 48 | 18 | 35140242 | |
| Pubmed | 2.60e-13 | 83 | 48 | 8 | 28794006 | ||
| Pubmed | 2.67e-13 | 21 | 48 | 6 | 19596656 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | BCL9L NCOA3 NCOA6 ZNF536 ARID1B KMT2D NCOA1 CHD7 BCL9 CREBBP EP300 | 1.53e-12 | 351 | 48 | 11 | 38297188 |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | BCL9L NCOA3 NCOA6 ARID1B KMT2D RBM12 NUP155 BCL9 CREBBP CNOT2 EP300 | 2.61e-11 | 457 | 48 | 11 | 32344865 |
| Pubmed | Temporal/spatial expression of nuclear receptor coactivators in the mouse lung. | 4.78e-11 | 6 | 48 | 4 | 11076796 | |
| Pubmed | 4.78e-11 | 6 | 48 | 4 | 10973497 | ||
| Pubmed | NCOA3 NCOA6 ZNF536 ARID1B KMT2D MED8 NCOA1 CHD7 BCL9 SS18 CREBBP EP300 | 5.00e-11 | 638 | 48 | 12 | 31182584 | |
| Pubmed | 6.17e-11 | 20 | 48 | 5 | 11877444 | ||
| Pubmed | NCOA3 NCOA6 ARID1B KMT2D CAD RBM12 TCF12 MED8 NCOA1 MLLT6 CHD7 BCL9 CREBBP EP300 | 1.69e-10 | 1103 | 48 | 14 | 34189442 | |
| Pubmed | Regulation of SRC-3 (pCIP/ACTR/AIB-1/RAC-3/TRAM-1) Coactivator activity by I kappa B kinase. | 2.23e-10 | 8 | 48 | 4 | 11971985 | |
| Pubmed | 2.23e-10 | 8 | 48 | 4 | 17475621 | ||
| Pubmed | 1.19e-09 | 78 | 48 | 6 | 28611094 | ||
| Pubmed | 1.57e-09 | 12 | 48 | 4 | 12189208 | ||
| Pubmed | Proteomic analysis of steady-state nuclear hormone receptor coactivator complexes. | 2.01e-09 | 85 | 48 | 6 | 16051665 | |
| Pubmed | 2.10e-09 | 157 | 48 | 7 | 30186101 | ||
| Pubmed | Mutual synergistic folding in recruitment of CBP/p300 by p160 nuclear receptor coactivators. | 2.47e-09 | 3 | 48 | 3 | 11823864 | |
| Pubmed | 3.16e-09 | 14 | 48 | 4 | 12482968 | ||
| Pubmed | 7.50e-09 | 17 | 48 | 4 | 19183483 | ||
| Pubmed | 9.86e-09 | 4 | 48 | 3 | 10551785 | ||
| Pubmed | 9.86e-09 | 4 | 48 | 3 | 16227615 | ||
| Pubmed | 9.86e-09 | 4 | 48 | 3 | 33589584 | ||
| Pubmed | 9.86e-09 | 4 | 48 | 3 | 28398509 | ||
| Pubmed | 9.86e-09 | 4 | 48 | 3 | 12208951 | ||
| Pubmed | 9.86e-09 | 4 | 48 | 3 | 11463834 | ||
| Pubmed | CBP/p300 interact with and function as transcriptional coactivators of BRCA1. | 9.86e-09 | 4 | 48 | 3 | 10655477 | |
| Pubmed | 9.86e-09 | 4 | 48 | 3 | 11113179 | ||
| Pubmed | 9.86e-09 | 4 | 48 | 3 | 11701890 | ||
| Pubmed | 9.86e-09 | 4 | 48 | 3 | 15449938 | ||
| Pubmed | 1.60e-08 | 57 | 48 | 5 | 18022353 | ||
| Pubmed | 2.46e-08 | 5 | 48 | 3 | 21670263 | ||
| Pubmed | 2.46e-08 | 5 | 48 | 3 | 12714702 | ||
| Pubmed | Transcription factor-specific requirements for coactivators and their acetyltransferase functions. | 2.46e-08 | 5 | 48 | 3 | 9445475 | |
| Pubmed | 2.46e-08 | 5 | 48 | 3 | 14722092 | ||
| Pubmed | SRC-1 and GRIP1 coactivate transcription with hepatocyte nuclear factor 4. | 2.46e-08 | 5 | 48 | 3 | 9812974 | |
| Pubmed | 2.46e-08 | 5 | 48 | 3 | 11912212 | ||
| Pubmed | 2.46e-08 | 5 | 48 | 3 | 10224118 | ||
| Pubmed | 4.92e-08 | 6 | 48 | 3 | 10777539 | ||
| Pubmed | Role of CBP in regulating HIF-1-mediated activation of transcription. | 4.92e-08 | 6 | 48 | 3 | 15615775 | |
| Pubmed | Roles of coactivators in hypoxic induction of the erythropoietin gene. | 4.92e-08 | 6 | 48 | 3 | 20368990 | |
| Pubmed | 4.92e-08 | 6 | 48 | 3 | 16923966 | ||
| Pubmed | 4.92e-08 | 6 | 48 | 3 | 10497212 | ||
| Pubmed | CBP-mediated FOXO-1 acetylation inhibits pancreatic tumor growth by targeting SirT. | 4.92e-08 | 6 | 48 | 3 | 24419059 | |
| Pubmed | Transforming activity of MECT1-MAML2 fusion oncoprotein is mediated by constitutive CREB activation. | 4.92e-08 | 6 | 48 | 3 | 15961999 | |
| Pubmed | 6.38e-08 | 28 | 48 | 4 | 24880616 | ||
| Pubmed | 6.66e-08 | 152 | 48 | 6 | 38360978 | ||
| Pubmed | BRCA1-IRIS regulates cyclin D1 expression in breast cancer cells. | 8.60e-08 | 7 | 48 | 3 | 16860316 | |
| Pubmed | The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. | 8.60e-08 | 7 | 48 | 3 | 9192892 | |
| Pubmed | Chromatin remodelling by the glucocorticoid receptor requires the BRG1 complex. | 8.60e-08 | 7 | 48 | 3 | 9590696 | |
| Pubmed | 8.60e-08 | 7 | 48 | 3 | 12709428 | ||
| Pubmed | 1.37e-07 | 8 | 48 | 3 | 12082103 | ||
| Pubmed | 1.37e-07 | 8 | 48 | 3 | 8616895 | ||
| Pubmed | 1.37e-07 | 8 | 48 | 3 | 10490106 | ||
| Pubmed | 2.06e-07 | 9 | 48 | 3 | 9346901 | ||
| Pubmed | 2.06e-07 | 9 | 48 | 3 | 19176441 | ||
| Pubmed | Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of the TGFbeta pathway. | 2.94e-07 | 10 | 48 | 3 | 16751102 | |
| Pubmed | Natural helix 9 mutants of PPARγ differently affect its transcriptional activity. | 2.94e-07 | 10 | 48 | 3 | 30595551 | |
| Pubmed | 2.94e-07 | 10 | 48 | 3 | 15808510 | ||
| Pubmed | 2.94e-07 | 10 | 48 | 3 | 11163245 | ||
| Pubmed | 4.04e-07 | 11 | 48 | 3 | 10454579 | ||
| Pubmed | Corepressors selectively control the transcriptional activity of PPARgamma in adipocytes. | 4.04e-07 | 11 | 48 | 3 | 15681609 | |
| Pubmed | 4.04e-07 | 11 | 48 | 3 | 36613751 | ||
| Pubmed | 4.99e-07 | 46 | 48 | 4 | 20301533 | ||
| Pubmed | 5.38e-07 | 12 | 48 | 3 | 15383283 | ||
| Pubmed | Histone acetyltransferase-dependent chromatin remodeling and the vascular clock. | 5.38e-07 | 12 | 48 | 3 | 14645221 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 5.88e-07 | 220 | 48 | 6 | 35785414 | |
| Pubmed | 6.99e-07 | 13 | 48 | 3 | 11266503 | ||
| Pubmed | MED25 is distinct from TRAP220/MED1 in cooperating with CBP for retinoid receptor activation. | 8.88e-07 | 14 | 48 | 3 | 17641689 | |
| Pubmed | Multiplexed molecular interactions of nuclear receptors using fluorescent microspheres. | 8.88e-07 | 14 | 48 | 3 | 11500849 | |
| Pubmed | E protein silencing by the leukemogenic AML1-ETO fusion protein. | 8.88e-07 | 14 | 48 | 3 | 15333839 | |
| Pubmed | 1.11e-06 | 15 | 48 | 3 | 9267036 | ||
| Pubmed | 1.11e-06 | 15 | 48 | 3 | 10567404 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 1.20e-06 | 398 | 48 | 7 | 35016035 | |
| Pubmed | 1.24e-06 | 250 | 48 | 6 | 18660489 | ||
| Pubmed | A human RNA polymerase II complex containing factors that modify chromatin structure. | 1.36e-06 | 16 | 48 | 3 | 9710619 | |
| Pubmed | 1.65e-06 | 17 | 48 | 3 | 28291835 | ||
| Pubmed | 1.85e-06 | 425 | 48 | 7 | 24999758 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 27881875 | ||
| Pubmed | Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia. | 1.87e-06 | 2 | 48 | 2 | 34845315 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 19729597 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 15860545 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 29460469 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 28675294 | ||
| Pubmed | Expression of p300 and CBP is associated with poor prognosis in small cell lung cancer. | 1.87e-06 | 2 | 48 | 2 | 24551300 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 33911074 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 9018065 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 24648406 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 30135524 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 39287984 | ||
| Pubmed | Distribution of co-activators CBP and p300 during mouse oocyte and embryo development. | 1.87e-06 | 2 | 48 | 2 | 16596650 | |
| Pubmed | The coactivator SRC-1 is an essential coordinator of hepatic glucose production. | 1.87e-06 | 2 | 48 | 2 | 21109193 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 16141356 | ||
| Pubmed | The p300 and CBP Transcriptional Coactivators Are Required for β-Cell and α-Cell Proliferation. | 1.87e-06 | 2 | 48 | 2 | 29217654 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 24875297 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 20717166 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 10049825 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 38811552 | ||
| Pubmed | CBP/p300 acetyltransferase activity in hematologic malignancies. | 1.87e-06 | 2 | 48 | 2 | 27380996 | |
| Pubmed | CREBBP and p300 lysine acetyl transferases in the DNA damage response. | 1.87e-06 | 2 | 48 | 2 | 29170789 | |
| Interaction | TBXT interactions | NCOA3 NCOA6 ZNF536 ARID1B KMT2D CAD MED8 CHD7 BCL9 SS18 CREBBP EP300 | 3.26e-17 | 116 | 47 | 12 | int:TBXT |
| Interaction | SP7 interactions | BCL9L NCOA3 NCOA6 ZNF536 ARID1B KMT2D CAD RBM12 NCOA1 CHD7 BCL9 SS18 CREBBP EP300 | 5.12e-15 | 304 | 47 | 14 | int:SP7 |
| Interaction | EGR2 interactions | BCL9L NCOA3 NCOA6 ZNF536 ARID1B KMT2D NCOA1 CHD7 BCL9 CREBBP EP300 | 1.59e-13 | 171 | 47 | 11 | int:EGR2 |
| Interaction | HNF4A interactions | FOXO1 NCOA3 NCOA6 ARID1B GTF2H1 KMT2D MED8 NCOA1 CHD7 SS18 CREBBP EP300 | 1.12e-12 | 275 | 47 | 12 | int:HNF4A |
| Interaction | GCM1 interactions | 3.11e-12 | 68 | 47 | 8 | int:GCM1 | |
| Interaction | CRX interactions | BCL9L NCOA3 ZNF536 ARID1B KMT2D NCOA1 MLLT6 CHD7 BCL9 CREBBP EP300 | 1.20e-11 | 254 | 47 | 11 | int:CRX |
| Interaction | GATA3 interactions | NCOA3 ZNF536 ARID1B KMT2D RBM12 MLLT6 CHD7 BCL9 CREBBP EP300 | 1.43e-11 | 187 | 47 | 10 | int:GATA3 |
| Interaction | PAX9 interactions | 1.62e-11 | 130 | 47 | 9 | int:PAX9 | |
| Interaction | MYOD1 interactions | 2.06e-11 | 194 | 47 | 10 | int:MYOD1 | |
| Interaction | GSC interactions | 2.38e-11 | 87 | 47 | 8 | int:GSC | |
| Interaction | GATA2 interactions | 2.65e-11 | 199 | 47 | 10 | int:GATA2 | |
| Interaction | SOX9 interactions | 5.78e-11 | 97 | 47 | 8 | int:SOX9 | |
| Interaction | ERG interactions | 8.14e-11 | 223 | 47 | 10 | int:ERG | |
| Interaction | PPARG interactions | FOXO1 NCOA3 NCOA6 ZNF536 ARID1B KMT2D NCOA1 MLLT6 IKBKB CREBBP EP300 | 9.17e-11 | 307 | 47 | 11 | int:PPARG |
| Interaction | FOS interactions | NCOA3 NCOA6 ARID1B KMT2D TCF12 MED8 NCOA1 BCL9 SS18 CREBBP EP300 | 1.09e-10 | 312 | 47 | 11 | int:FOS |
| Interaction | TBR1 interactions | 1.99e-10 | 113 | 47 | 8 | int:TBR1 | |
| Interaction | ETV4 interactions | 2.28e-10 | 69 | 47 | 7 | int:ETV4 | |
| Interaction | PAX7 interactions | 4.21e-10 | 124 | 47 | 8 | int:PAX7 | |
| Interaction | HNF1B interactions | 4.87e-10 | 190 | 47 | 9 | int:HNF1B | |
| Interaction | SOX7 interactions | 7.84e-10 | 82 | 47 | 7 | int:SOX7 | |
| Interaction | TLE3 interactions | BCL9L NCOA3 ARID1B KMT2D RBM12 TCF12 NCOA1 MLLT6 BCL9 CREBBP EP300 | 7.87e-10 | 376 | 47 | 11 | int:TLE3 |
| Interaction | SOX10 interactions | 1.78e-09 | 92 | 47 | 7 | int:SOX10 | |
| Interaction | FOXI1 interactions | 1.78e-09 | 92 | 47 | 7 | int:FOXI1 | |
| Interaction | SOX17 interactions | 2.23e-09 | 95 | 47 | 7 | int:SOX17 | |
| Interaction | SMG7 interactions | NCOA3 NCOA6 ARID1B KMT2D RBM12 NCOA1 MLLT6 BCL9 CREBBP CNOT2 | 2.64e-09 | 319 | 47 | 10 | int:SMG7 |
| Interaction | NUP35 interactions | BCL9L NCOA3 NCOA6 ARID1B KMT2D RBM12 NUP155 BCL9 CREBBP CNOT2 EP300 | 2.77e-09 | 424 | 47 | 11 | int:NUP35 |
| Interaction | TLX1 interactions | 6.49e-09 | 175 | 47 | 8 | int:TLX1 | |
| Interaction | PAX8 interactions | 6.66e-09 | 111 | 47 | 7 | int:PAX8 | |
| Interaction | TEAD1 interactions | 6.79e-09 | 176 | 47 | 8 | int:TEAD1 | |
| Interaction | PAX6 interactions | NCOA3 NCOA6 ZNF536 ARID1B KMT2D MLLT6 CHD7 BCL9 CREBBP EP300 | 9.84e-09 | 366 | 47 | 10 | int:PAX6 |
| Interaction | KLF5 interactions | 1.51e-08 | 195 | 47 | 8 | int:KLF5 | |
| Interaction | HOXB2 interactions | 1.98e-08 | 36 | 47 | 5 | int:HOXB2 | |
| Interaction | TLX3 interactions | 2.03e-08 | 291 | 47 | 9 | int:TLX3 | |
| Interaction | FEV interactions | 2.07e-08 | 203 | 47 | 8 | int:FEV | |
| Interaction | AR interactions | FOXO1 BCL9L NCOA3 NCOA6 ARID1B GTF2H1 KMT2D RBM12 MED8 NCOA1 CHD7 BCL9 CREBBP EP300 | 3.33e-08 | 992 | 47 | 14 | int:AR |
| Interaction | IRF4 interactions | 4.40e-08 | 85 | 47 | 6 | int:IRF4 | |
| Interaction | CREBBP interactions | FOXO1 NCOA3 NCOA6 ARID1B KMT2D TCF12 NCOA1 MAML2 IKBKB CREBBP EP300 | 9.62e-08 | 599 | 47 | 11 | int:CREBBP |
| Interaction | LHX2 interactions | 2.10e-07 | 183 | 47 | 7 | int:LHX2 | |
| Interaction | NR3C1 interactions | NCOA3 NCOA6 ZNF536 ARID1B KMT2D SGTA MED8 NCOA1 CHD7 BCL9 SS18 CREBBP EP300 | 2.20e-07 | 974 | 47 | 13 | int:NR3C1 |
| Interaction | ETS1 interactions | 3.63e-07 | 121 | 47 | 6 | int:ETS1 | |
| Interaction | CEBPA interactions | NCOA3 NCOA6 ARID1B KMT2D CAD RBM12 TCF12 MED8 NCOA1 MLLT6 CHD7 BCL9 CREBBP EP300 | 5.46e-07 | 1245 | 47 | 14 | int:CEBPA |
| Interaction | MYB interactions | 6.34e-07 | 133 | 47 | 6 | int:MYB | |
| Interaction | RARA interactions | 7.98e-07 | 223 | 47 | 7 | int:RARA | |
| Interaction | NCOA2 interactions | 8.94e-07 | 141 | 47 | 6 | int:NCOA2 | |
| Interaction | NCOA1 interactions | 1.10e-06 | 146 | 47 | 6 | int:NCOA1 | |
| Interaction | ELF5 interactions | 1.14e-06 | 147 | 47 | 6 | int:ELF5 | |
| Interaction | HNF1A interactions | 1.17e-06 | 80 | 47 | 5 | int:HNF1A | |
| Interaction | PPARGC1A interactions | 1.32e-06 | 82 | 47 | 5 | int:PPARGC1A | |
| Interaction | EYA4 interactions | 1.42e-06 | 243 | 47 | 7 | int:EYA4 | |
| Interaction | SMARCC2 interactions | 1.42e-06 | 353 | 47 | 8 | int:SMARCC2 | |
| Interaction | E2F5 interactions | 1.45e-06 | 36 | 47 | 4 | int:E2F5 | |
| Interaction | PGR interactions | 1.49e-06 | 84 | 47 | 5 | int:PGR | |
| Interaction | PAX2 interactions | 1.58e-06 | 85 | 47 | 5 | int:PAX2 | |
| Interaction | ASF1A interactions | 1.67e-06 | 249 | 47 | 7 | int:ASF1A | |
| Interaction | KLF4 interactions | 1.87e-06 | 160 | 47 | 6 | int:KLF4 | |
| Interaction | TFF1 interactions | 2.47e-06 | 41 | 47 | 4 | int:TFF1 | |
| Interaction | SMAD2 interactions | 2.71e-06 | 385 | 47 | 8 | int:SMAD2 | |
| Interaction | GATA1 interactions | 2.75e-06 | 171 | 47 | 6 | int:GATA1 | |
| Interaction | EPAS1 interactions | 2.94e-06 | 173 | 47 | 6 | int:EPAS1 | |
| Interaction | ALG13 interactions | 4.07e-06 | 183 | 47 | 6 | int:ALG13 | |
| Interaction | THRB interactions | 4.47e-06 | 186 | 47 | 6 | int:THRB | |
| Interaction | PYGO2 interactions | 4.69e-06 | 48 | 47 | 4 | int:PYGO2 | |
| Interaction | NR1I2 interactions | 4.69e-06 | 48 | 47 | 4 | int:NR1I2 | |
| Interaction | NFIA interactions | 4.75e-06 | 188 | 47 | 6 | int:NFIA | |
| Interaction | THRA interactions | 5.91e-06 | 111 | 47 | 5 | int:THRA | |
| Interaction | E2F1 interactions | 6.78e-06 | 200 | 47 | 6 | int:E2F1 | |
| Interaction | MAML2 interactions | 7.90e-06 | 17 | 47 | 3 | int:MAML2 | |
| Interaction | TRIP4 interactions | 8.03e-06 | 206 | 47 | 6 | int:TRIP4 | |
| Interaction | SMAD3 interactions | 8.10e-06 | 447 | 47 | 8 | int:SMAD3 | |
| Interaction | TPRX2 interactions | 8.72e-06 | 56 | 47 | 4 | int:TPRX2 | |
| Interaction | NR1H3 interactions | 1.00e-05 | 58 | 47 | 4 | int:NR1H3 | |
| Interaction | SMARCA4 interactions | 1.03e-05 | 462 | 47 | 8 | int:SMARCA4 | |
| Interaction | NEUROG1 interactions | 1.12e-05 | 19 | 47 | 3 | int:NEUROG1 | |
| Interaction | VDR interactions | 1.14e-05 | 127 | 47 | 5 | int:VDR | |
| Interaction | ETS2 interactions | 1.23e-05 | 61 | 47 | 4 | int:ETS2 | |
| Interaction | NCOA3 interactions | 1.29e-05 | 224 | 47 | 6 | int:NCOA3 | |
| Interaction | SOX2 interactions | BCL9L NCOA3 NCOA6 ZNF536 CELSR1 ARID1B KMT2D TCF12 CHD7 BCL9 EFCAB7 SS18 EP300 | 1.48e-05 | 1422 | 47 | 13 | int:SOX2 |
| Interaction | RXRB interactions | 1.68e-05 | 66 | 47 | 4 | int:RXRB | |
| Interaction | SOX15 interactions | 1.89e-05 | 141 | 47 | 5 | int:SOX15 | |
| Interaction | NFIB interactions | 1.96e-05 | 142 | 47 | 5 | int:NFIB | |
| Interaction | CITED2 interactions | 2.04e-05 | 23 | 47 | 3 | int:CITED2 | |
| Interaction | NCOA6 interactions | 2.16e-05 | 145 | 47 | 5 | int:NCOA6 | |
| Interaction | NR6A1 interactions | 2.32e-05 | 24 | 47 | 3 | int:NR6A1 | |
| Interaction | TBP interactions | 2.57e-05 | 253 | 47 | 6 | int:TBP | |
| Interaction | ARNT interactions | 2.69e-05 | 255 | 47 | 6 | int:ARNT | |
| Interaction | SMARCC1 interactions | 2.82e-05 | 384 | 47 | 7 | int:SMARCC1 | |
| Interaction | TP53BP1 interactions | 2.88e-05 | 533 | 47 | 8 | int:TP53BP1 | |
| Interaction | LHX4 interactions | 4.14e-05 | 166 | 47 | 5 | int:LHX4 | |
| Interaction | IRF1 interactions | 4.17e-05 | 83 | 47 | 4 | int:IRF1 | |
| Interaction | ARID1A interactions | 4.19e-05 | 276 | 47 | 6 | int:ARID1A | |
| Interaction | RXRA interactions | 4.51e-05 | 169 | 47 | 5 | int:RXRA | |
| Interaction | KMT2D interactions | 4.51e-05 | 169 | 47 | 5 | int:KMT2D | |
| Interaction | TWIST1 interactions | 4.64e-05 | 170 | 47 | 5 | int:TWIST1 | |
| Interaction | STAT6 interactions | 5.02e-05 | 87 | 47 | 4 | int:STAT6 | |
| Interaction | SMARCE1 interactions | 5.20e-05 | 287 | 47 | 6 | int:SMARCE1 | |
| Interaction | DEFB131A interactions | 5.30e-05 | 5 | 47 | 2 | int:DEFB131A | |
| Interaction | KLF15 interactions | 5.51e-05 | 290 | 47 | 6 | int:KLF15 | |
| Interaction | NEUROD1 interactions | 5.62e-05 | 32 | 47 | 3 | int:NEUROD1 | |
| Interaction | CACNB3 interactions | 5.62e-05 | 32 | 47 | 3 | int:CACNB3 | |
| Interaction | NR1H4 interactions | 5.62e-05 | 32 | 47 | 3 | int:NR1H4 | |
| Cytoband | 9q22.3 | 7.32e-05 | 12 | 49 | 2 | 9q22.3 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 2.44e-08 | 17 | 34 | 4 | 486 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 5.15e-04 | 18 | 34 | 2 | 91 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 1.00e-03 | 25 | 34 | 2 | 775 | |
| GeneFamily | Basic helix-loop-helix proteins | 1.14e-03 | 110 | 34 | 3 | 420 | |
| GeneFamily | PHD finger proteins | 1.24e-02 | 90 | 34 | 2 | 88 | |
| Coexpression | GRESHOCK_CANCER_COPY_NUMBER_UP | 1.20e-07 | 323 | 48 | 8 | M9150 | |
| Coexpression | GSE27786_ERYTHROBLAST_VS_NEUTROPHIL_DN | 1.72e-06 | 200 | 48 | 6 | M4876 | |
| Coexpression | GSE19941_UNSTIM_VS_LPS_STIM_IL10_KO_MACROPHAGE_UP | 3.15e-05 | 199 | 48 | 5 | M8105 | |
| Coexpression | REN_ALVEOLAR_RHABDOMYOSARCOMA_UP | 3.28e-05 | 99 | 48 | 4 | M768 | |
| CoexpressionAtlas | alpha beta T cells, T.4Nve.MLN, 4+ 8- 25- 62Lhi 44lo, Lymph Node, avg-3 | 1.15e-05 | 344 | 48 | 7 | GSM538377_500 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.49e-06 | 197 | 49 | 5 | 6d0d68d460243a0259ada93ebda40fa7b3088eeb | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.36e-05 | 152 | 49 | 4 | 621e9b33cd3bb1c7b7d0633069f286b203e3d9c0 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.42e-05 | 153 | 49 | 4 | 1524557514668f515ac1bbe847611f564b265b42 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.33e-05 | 166 | 49 | 4 | 94636dbc039f794c735960c3425e00bdd5523602 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.09e-05 | 175 | 49 | 4 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.27e-05 | 177 | 49 | 4 | b59967219f7d874805768e247c0eb2bc4d4420c8 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.97e-05 | 184 | 49 | 4 | a2191dd5546efd357b23e625beb3c5820476f243 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.07e-05 | 185 | 49 | 4 | e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.07e-05 | 185 | 49 | 4 | e58a009aaf342be019a909747b1895d5987d4daf | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.18e-05 | 186 | 49 | 4 | 6add08d4ca019ff2864acdd5ec2c66a59a574591 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.29e-05 | 187 | 49 | 4 | 97e520705491c8f52a32025311a9fa7b9176979a | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 5.29e-05 | 187 | 49 | 4 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.40e-05 | 188 | 49 | 4 | b04fd6a724c117eb9a979c29b91f90113feb7a5c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.40e-05 | 188 | 49 | 4 | 505b6b4277d7dea87aee27191d0acca67928b8e6 | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.40e-05 | 188 | 49 | 4 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.40e-05 | 188 | 49 | 4 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.40e-05 | 188 | 49 | 4 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.51e-05 | 189 | 49 | 4 | 7ab1cfc1657277858339f7258a0c4ae9cb42fdf8 | |
| ToppCell | Mesenchymal-airway_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 5.63e-05 | 190 | 49 | 4 | 645e56b02edc3702c7db917b8ecd5eed0decaf71 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.63e-05 | 190 | 49 | 4 | 2de8e4cfeee350a9a76af749d6ce58d948c129b8 | |
| ToppCell | Control-Lymphoid_B-B_intermediate|Control / Disease group, lineage and cell class | 5.74e-05 | 191 | 49 | 4 | 0082181dbc39c7c4fd3aa34c3ed61439548e844b | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.74e-05 | 191 | 49 | 4 | 2b056cbe2e82e056e1f798974999378460eb1d16 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.74e-05 | 191 | 49 | 4 | f3158cedf67e3b90aa94ea1f61c72c33aaa2d5ba | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.74e-05 | 191 | 49 | 4 | a90c8ab2077e52bbc998457c85a1b9867f9c8c93 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 5.86e-05 | 192 | 49 | 4 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.98e-05 | 193 | 49 | 4 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 5.98e-05 | 193 | 49 | 4 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | IPF-Epithelial-Mesothelial|Epithelial / Disease state, Lineage and Cell class | 6.10e-05 | 194 | 49 | 4 | d8a26da856a85e3d001d406e992cb18fdd58baef | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 6.22e-05 | 195 | 49 | 4 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 6.22e-05 | 195 | 49 | 4 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 6.35e-05 | 196 | 49 | 4 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | RA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 6.35e-05 | 196 | 49 | 4 | e8cbda03837f1f26470a9d93aa7fdaa04e08e38a | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.60e-05 | 198 | 49 | 4 | a1b310274aa9b3d2aa1fe9488d67422bf4ac81d2 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 6.60e-05 | 198 | 49 | 4 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.60e-05 | 198 | 49 | 4 | a781fd35a7cda8b7760c2e3ddccaac7aac26c979 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.60e-05 | 198 | 49 | 4 | 76aff381403bc5a8a9cc73eb1e5dbdc0bac7de6c | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.60e-05 | 198 | 49 | 4 | df399674345c45738d765a8354ea8d1484572c34 | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-gd_T|COVID-19_Mild / Disease group, lineage and cell class | 6.60e-05 | 198 | 49 | 4 | 6aea5d00c417708f05b6d2dfe5a962d80864f8eb | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-oligodendrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.73e-05 | 199 | 49 | 4 | 67d8c7e5356f5d409d4f98e8338cf6c499fd7aee | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 6.73e-05 | 199 | 49 | 4 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Control-Control-Lymphocyte-B-B_intermediate|Control / Disease, condition lineage and cell class | 6.73e-05 | 199 | 49 | 4 | ee6f07eec7edfe41d2f7fcb0b509ce00e99a6a95 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-gd_T|COVID-19_Mild / Disease, condition lineage and cell class | 6.86e-05 | 200 | 49 | 4 | 6560753d3df2f87860b52052d4881aa45410f666 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-ADAMTSL1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.86e-05 | 200 | 49 | 4 | e1fca7ee2dc18c7fded53c3561f519c1fcd9767a | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.86e-05 | 200 | 49 | 4 | 0e85c90719d9ec51a566e230c9dd2909d8df1f52 | |
| ToppCell | mild-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.86e-05 | 200 | 49 | 4 | d8aec4904c9420b8f9d7508658ba1e36c66cdfcc | |
| ToppCell | Macroglial|World / cells hierarchy compared to all cells using T-Statistic | 6.86e-05 | 200 | 49 | 4 | e6935ad49216d2500c15c05cbc2b89402c65e838 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-ADAMTSL1-L1-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.86e-05 | 200 | 49 | 4 | 4409471479dd7c0f770bcb84ba7b3652c4706743 | |
| ToppCell | mild-gd_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.86e-05 | 200 | 49 | 4 | 109f673a4967ffa52270a0b4f818b3461288db44 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.48e-04 | 111 | 49 | 3 | bb59f1909645fd512f0ea806e5593d4a1c6e25d9 | |
| ToppCell | Cerebellum-Macroglia-OLIGODENDROCYTE|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.75e-04 | 115 | 49 | 3 | 15b2c11225802cc15c01165d84a755432f02d82f | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Striatum / BrainAtlas - Mouse McCarroll V32 | 4.21e-04 | 133 | 49 | 3 | d5326a6ccada5ae6d3e8f7d4a858c90050e23c5b | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-9|TCGA-Brain / Sample_Type by Project: Shred V9 | 4.31e-04 | 134 | 49 | 3 | 2647453f44b0e0a8f27ef9bba750e99eb40efc8b | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-like-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.10e-04 | 142 | 49 | 3 | 5690eee2ce1ecd02e34eac4193578bd13c4228b9 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD8-Trm/em_CD8|GI_small-bowel / Manually curated celltypes from each tissue | 5.31e-04 | 144 | 49 | 3 | a4bb274d553c29c8299354de757ecc5634008c68 | |
| ToppCell | 368C-Myeloid-Macrophage-FABP4+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 5.53e-04 | 146 | 49 | 3 | 5b2608b56204dda9a773988f42ff00a9fa743a39 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.21e-04 | 152 | 49 | 3 | 8ff5a178a8f3550d89a003c0858820aab3773386 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.58e-04 | 155 | 49 | 3 | cd7d95cbcad248670e531d80bb83c55e36ebc573 | |
| ToppCell | facs-Liver-Hepatocytes|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.70e-04 | 156 | 49 | 3 | e2cda3ad4e5f44a80133864c5a38b766afb952ce | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.83e-04 | 157 | 49 | 3 | b9d04ee417c0d8ea0801d10f1c54e138587009fd | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-Epcam____proximal_tube_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.95e-04 | 158 | 49 | 3 | 1d78578dc1f8ba43dacdccae1082c0b9d749f64d | |
| ToppCell | COVID-CD4-CD4_Treg|COVID / Condition, Cell_class and T cell subcluster | 7.08e-04 | 159 | 49 | 3 | 037cd97c41eb2f91fd3f69bbb3ffdfd6c0158410 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Myofibro_1|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 7.21e-04 | 160 | 49 | 3 | 5cd4fbbd2ce671a8377416eff94041a111375dee | |
| ToppCell | CD8+_Memory_T_cell-FLU-1|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 7.48e-04 | 162 | 49 | 3 | 76f39935763848ea6e7917b2f9f1432c543063d9 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Paneth|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.48e-04 | 162 | 49 | 3 | 768a566e76923323c1f197f60bab472a8784490b | |
| ToppCell | facs-Trachea-18m-Epithelial-glandular_epithelial-lung_secretory_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.75e-04 | 164 | 49 | 3 | cdb8cd2d6b369189ea77e4946738e2816d502e03 | |
| ToppCell | facs-Trachea-18m-Epithelial-glandular_epithelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.75e-04 | 164 | 49 | 3 | 5dbfcdd450f652b16d97da53b528d4584b0eabcf | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell-D231|Adult / Lineage, Cell type, age group and donor | 7.75e-04 | 164 | 49 | 3 | 3d8ff70fe5582d1fb56b338be8b76fa1428b3657 | |
| ToppCell | facs-Trachea-18m-Epithelial-glandular_epithelial-lung_secretory_cell-mucous|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.75e-04 | 164 | 49 | 3 | f1423f4434af4af9c60c8a5b0b0abec4a7df9401 | |
| ToppCell | facs-Trachea-nan-18m-Epithelial-mucus_secreting_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.88e-04 | 165 | 49 | 3 | 7e7643834ed483aec04f513cca38d6367fda9ff8 | |
| ToppCell | LV-16._Neuronal|World / Chamber and Cluster_Paper | 7.88e-04 | 165 | 49 | 3 | 6ed52cb756d21addf46c7f6c457458b01339fe04 | |
| ToppCell | NS-critical-d_0-4-Epithelial-unknown_epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.02e-04 | 166 | 49 | 3 | dd02bbe4af609c6348dc92417254f4740f2900a8 | |
| ToppCell | facs-Lung-3m-Epithelial-alveolar_epithelial-type_I_pneumocyte-type_1_alveolar_epithelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.16e-04 | 167 | 49 | 3 | 9f2661729a2d58e17a9203a563d538c08a3dbbbc | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell|Adult / Lineage, Cell type, age group and donor | 8.16e-04 | 167 | 49 | 3 | d584a8548a5317bd9686b3be8246ae6ed568796b | |
| ToppCell | facs-Lung-3m-Epithelial-alveolar_epithelial-type_I_pneumocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.16e-04 | 167 | 49 | 3 | bebc2493a2ee41920b21c2b774a1c5a9619315c4 | |
| ToppCell | COVID-19-Heart-Neuronal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.31e-04 | 168 | 49 | 3 | 88c2c574f428c2502b5fe099bd73b0758f668ef6 | |
| ToppCell | LV-16._Neuronal|LV / Chamber and Cluster_Paper | 8.45e-04 | 169 | 49 | 3 | a8fc8ab0f0757e939e213efb61c03cfe390bf7d2 | |
| ToppCell | RA-01._Fibroblast_I|RA / Chamber and Cluster_Paper | 8.45e-04 | 169 | 49 | 3 | 6373562ab3b1765060212a6a53d6543e7e942e80 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.45e-04 | 169 | 49 | 3 | b6b5bb6408c1305a00719e1b88a5e1202081faf3 | |
| ToppCell | NS-critical-d_0-4-Lymphoid-B_cell|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.74e-04 | 171 | 49 | 3 | bd1ebd9037a740ad8c01c460d778b0973d8b56df | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c12-MKI67-TYROBP|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.89e-04 | 172 | 49 | 3 | fe3d0d8cb5f613ac2cfff450599698f1533a354f | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.04e-04 | 173 | 49 | 3 | 1f16d47f5548e257e4b17f8070c5619780a9c5fd | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-5_VIP_KCNJ2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.19e-04 | 174 | 49 | 3 | fdadac1eaab2c4a67e4832f0901df22e893add6a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-5_VIP_KCNJ2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.19e-04 | 174 | 49 | 3 | 8d8cf8ad17dcc364f867e36b10834a21c0e36ad2 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.19e-04 | 174 | 49 | 3 | f90ca117b729436cf452e2ddcec26ba525c5c13b | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)|Adult / Lineage, Cell type, age group and donor | 9.34e-04 | 175 | 49 | 3 | 4db1a3c284488b3f6de7568363f176d74e2a4587 | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-Tuft-related-Microfold_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.34e-04 | 175 | 49 | 3 | 8a37b2811f39bb9baa537e8755a29d559eb8185a | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)-D231|Adult / Lineage, Cell type, age group and donor | 9.34e-04 | 175 | 49 | 3 | 8d9f44a2633b71fb4d2b4a7d9530f954e07c4a18 | |
| ToppCell | P15-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.50e-04 | 176 | 49 | 3 | 792f414f5092aba14260b8e16378e793a822498e | |
| ToppCell | wk_15-18-Epithelial-PNS-Schwann_precursor|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 9.66e-04 | 177 | 49 | 3 | 5357359e6c2161a37f39a6b3b78449f5cbc327d1 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.66e-04 | 177 | 49 | 3 | 9ec7f1e64312d26d434b3312b58386715dbad644 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.66e-04 | 177 | 49 | 3 | 016277dfd59b1793fddaaadc2b3f41622d76ce3a | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.81e-04 | 178 | 49 | 3 | 09475e522dc1b8cf9ff1c25de5d1e3082b162948 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.81e-04 | 178 | 49 | 3 | 35de8f791b0e78a6caf52ff095f05e204a59e828 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.81e-04 | 178 | 49 | 3 | 08b4a497aca0aeabf4f6a8a55c05b56417b69e78 | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-Tuft-related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.81e-04 | 178 | 49 | 3 | a95bb77a2c2ce7c38989e6f971812f7ee9f5bd4b | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.81e-04 | 178 | 49 | 3 | 000d25f3f13cc76cf39c46c312c6fafc2ea4f368 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-Alveolar_Epithelial_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.97e-04 | 179 | 49 | 3 | 88dbec952507d84b85b08165eec80df99ed1e736 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-type_I_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.97e-04 | 179 | 49 | 3 | daf8189a22786171e2b629261cf720736aa4ebdb | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.97e-04 | 179 | 49 | 3 | 7394e77e665bf16d3733df91bb12907be460ab44 | |
| ToppCell | LA-01._Fibroblast_I|LA / Chamber and Cluster_Paper | 9.97e-04 | 179 | 49 | 3 | dcb6ec9ae72b13fe388b72dace2815293fafe8ee | |
| Drug | glutamin | 4.93e-06 | 461 | 48 | 8 | CID000000738 | |
| Drug | AC1Q68Z5 | 1.54e-05 | 386 | 48 | 7 | CID000000181 | |
| Drug | Phe-gly | 1.70e-05 | 73 | 48 | 4 | CID000098207 | |
| Disease | Diffuse Large B-Cell Lymphoma | 1.82e-06 | 55 | 47 | 4 | C0079744 | |
| Disease | Menke-Hennekam syndrome | 2.48e-06 | 2 | 47 | 2 | cv:C5681632 | |
| Disease | Rubinstein-Taybi syndrome (implicated_via_orthology) | 2.48e-06 | 2 | 47 | 2 | DOID:1933 (implicated_via_orthology) | |
| Disease | Rubinstein-Taybi syndrome | 2.48e-06 | 2 | 47 | 2 | cv:C0035934 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 2.48e-06 | 2 | 47 | 2 | C4551859 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 2.48e-06 | 2 | 47 | 2 | 180849 | |
| Disease | Rubinstein-Taybi syndrome due to CREBBP mutations | 2.48e-06 | 2 | 47 | 2 | cv:C4551859 | |
| Disease | carbamoyl phosphate synthetase I deficiency disease (implicated_via_orthology) | 2.48e-06 | 2 | 47 | 2 | DOID:9280 (implicated_via_orthology) | |
| Disease | Rubinstein-Taybi syndrome (is_implicated_in) | 2.48e-06 | 2 | 47 | 2 | DOID:1933 (is_implicated_in) | |
| Disease | Rubinstein-Taybi Syndrome | 2.48e-06 | 2 | 47 | 2 | C0035934 | |
| Disease | breast carcinoma (is_marker_for) | 3.79e-06 | 66 | 47 | 4 | DOID:3459 (is_marker_for) | |
| Disease | prostate cancer (is_marker_for) | 4.97e-06 | 156 | 47 | 5 | DOID:10283 (is_marker_for) | |
| Disease | Prostatic Neoplasms | 5.29e-06 | 616 | 47 | 8 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 5.29e-06 | 616 | 47 | 8 | C0376358 | |
| Disease | Congenital small ears | 3.87e-05 | 41 | 47 | 3 | C0152423 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.02e-04 | 152 | 47 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Microphthalmos | 1.35e-04 | 11 | 47 | 2 | C0026010 | |
| Disease | Lymphoma, Large-Cell, Follicular | 2.57e-04 | 15 | 47 | 2 | C0079745 | |
| Disease | Lymphoma, Small Cleaved-Cell, Follicular | 2.57e-04 | 15 | 47 | 2 | C0079765 | |
| Disease | Lymphoma, Mixed-Cell, Follicular | 2.57e-04 | 15 | 47 | 2 | C0079758 | |
| Disease | Lymphoma, Follicular, Grade 2 | 2.57e-04 | 15 | 47 | 2 | C1956132 | |
| Disease | Lymphoma, Follicular, Grade 3 | 2.57e-04 | 15 | 47 | 2 | C1956131 | |
| Disease | Lymphoma, Follicular, Grade 1 | 2.57e-04 | 15 | 47 | 2 | C1956130 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 2.64e-04 | 195 | 47 | 4 | DOID:1574 (implicated_via_orthology) | |
| Disease | T-Cell Lymphoma | 2.94e-04 | 16 | 47 | 2 | C0079772 | |
| Disease | acute lymphoblastic leukemia, response to antineoplastic agent | 4.17e-04 | 19 | 47 | 2 | EFO_0000220, GO_0097327 | |
| Disease | serum homoarginine measurement | 4.63e-04 | 20 | 47 | 2 | EFO_0005421 | |
| Disease | Lymphoma, Follicular | 4.63e-04 | 20 | 47 | 2 | C0024301 | |
| Disease | corneal hysteresis | 4.63e-04 | 20 | 47 | 2 | EFO_0010066 | |
| Disease | hypertension (biomarker_via_orthology) | 4.69e-04 | 227 | 47 | 4 | DOID:10763 (biomarker_via_orthology) | |
| Disease | Squamous cell carcinoma of esophagus | 4.73e-04 | 95 | 47 | 3 | C0279626 | |
| Disease | sphingomyelin 24:1 measurement | 6.15e-04 | 23 | 47 | 2 | EFO_0010398 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 7.09e-04 | 447 | 47 | 5 | EFO_0000694, MONDO_0100096 | |
| Disease | total blood protein measurement | 7.23e-04 | 449 | 47 | 5 | EFO_0004536 | |
| Disease | lipoprotein A measurement | 7.64e-04 | 112 | 47 | 3 | EFO_0006925 | |
| Disease | Sezary Syndrome | 8.50e-04 | 27 | 47 | 2 | C0036920 | |
| Disease | Squamous cell carcinoma | 1.03e-03 | 124 | 47 | 3 | C0007137 | |
| Disease | Lymphoma, Non-Hodgkin | 1.19e-03 | 32 | 47 | 2 | C0024305 | |
| Disease | Bladder Neoplasm | 1.45e-03 | 140 | 47 | 3 | C0005695 | |
| Disease | Malignant neoplasm of breast | 1.46e-03 | 1074 | 47 | 7 | C0006142 | |
| Disease | Malignant neoplasm of urinary bladder | 1.48e-03 | 141 | 47 | 3 | C0005684 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RLQKQNMLPNAAGMV | 651 | Q09472 | |
| QNMNPMQAGVQRAGL | 2131 | Q09472 | |
| QRLQMAGGSQLPMAS | 981 | P55198 | |
| MRNVQFPGMAPQNLG | 51 | Q8N139 | |
| QQMRTLNPLGNNPMN | 516 | Q92793 | |
| PVNRMQVSQGMNSFN | 711 | Q92793 | |
| MGGLNPQGQALNIMN | 2161 | Q92793 | |
| QQHLPLQGSSMGQMA | 2251 | Q92793 | |
| GAMSNLGMGQRQQFP | 1386 | Q8NFD5 | |
| LRMTNNQGILPAGIM | 341 | A6NGH8 | |
| MGGTPTNVATLNMNN | 1846 | Q9NYQ6 | |
| LMAMNTLQGNGSQNG | 231 | Q96NX9 | |
| RDQMQQAPGGLSQMG | 1871 | Q00975 | |
| TGMNQNLGLTNNTPM | 326 | Q9P2D1 | |
| GSGAPMNLNNNLNPM | 261 | Q9NTZ6 | |
| MANNLQKGNGGPMRL | 251 | Q86U06 | |
| LGSAMQNIQNLLQMP | 961 | P20742 | |
| DMQNPETGVRMQNQR | 26 | O75916 | |
| VTMRQGTVGMQPQQQ | 6 | P55040 | |
| MNASRLSQPGQLMSQ | 676 | O14920 | |
| MNPQQQRMAAIGTDK | 1 | Q99081 | |
| SLLQRNMTPQGLQIM | 906 | Q8NDA8 | |
| IGFMRPENGNPQQMQ | 746 | O75694 | |
| INNGQSQIMSGTLPM | 221 | Q8IZL2 | |
| LLQQMQNQPIAGMGY | 691 | Q8IZL2 | |
| QMSQTLNGQTMGPLR | 1031 | Q8IZL2 | |
| QNRSQDVRMNGPMGA | 141 | Q14686 | |
| QPSLMGIHGNMNNQQ | 581 | Q14686 | |
| QNQSNVMPGPAQIMR | 731 | Q14686 | |
| VQFTGQMSGQMLPQQ | 756 | Q14686 | |
| QMSGQMLPQQGPVNN | 761 | Q14686 | |
| RLELGNLGNPQMSQQ | 236 | Q13415 | |
| MSMANRGQNQPVLNI | 311 | P31327 | |
| QPNSRVLGQNVMMGP | 486 | Q12778 | |
| MGANGNRNSKLMEPN | 251 | A8K855 | |
| VNQLGNMQNMRLGPS | 36 | F2Z3M2 | |
| NNMPGMGINTQNPRI | 1051 | O00512 | |
| NQIQRVPGFGGMQSM | 606 | Q86UU0 | |
| NLPGQQGVQRGLNMS | 1376 | Q86UU0 | |
| QQMAQNQTAPMLELG | 121 | Q9Y264 | |
| MRLNMDGNNLIQIPS | 396 | O94769 | |
| RPMNENVQMNAQGGP | 251 | Q9BSE4 | |
| NIGNNTMNISLPGEM | 401 | P46059 | |
| NAAMGAAQGAMNQPQ | 206 | Q8TAC9 | |
| QQQPMLSGVQMAQAG | 231 | Q96G25 | |
| MPRATLGELNTMNNQ | 326 | O75674 | |
| PQIQQLMSGMISGGN | 241 | O43765 | |
| VGINMRSGMQQQITP | 1086 | Q15788 | |
| QMNQQGNFPLQGMHP | 1141 | Q9Y6Q9 | |
| QIGTNQSGMSQPVMQ | 126 | Q86VE3 | |
| MSQQVPSQLGMRQPG | 446 | Q86VE3 | |
| NMGALRMPFQQVQAQ | 201 | O15266 | |
| MRGMSNNTPQLNRSL | 86 | Q9NZN8 | |
| MQGGTQQAINQMVPN | 441 | P32780 | |
| QQGPRLRASNAMMNN | 321 | P28289 | |
| QNQMTMSQGQPMGNY | 176 | Q15532 | |
| GGQLPNNMAMALHRQ | 1016 | P27708 | |
| PMGSQMALLANQLGR | 76 | O15090 | |
| EQQFINQKMRPGSGM | 3761 | Q5THJ4 | |
| GSMTQNLLGPQQPML | 4146 | O14686 | |
| LNAQMLNGMIKQEPG | 266 | Q9Y2G1 |